7.2 | | Oasl2 | 'interleukin-28A; 1000 nanogram per milliliter' vs 'none' | compound | Transcription profiling by high throughput sequencing of murine small intestinal epithelial cells stimulated with interleukin-28A |
6.5 | | Oasl2 | '3D culture' vs '2D culture' | growth condition | mRNA-seq of mouse salivary gland cancer cells cultured in adherent or non-adherent culture |
6.4 | | Oasl2 | 'Lymphocytic choriomeningitis mammarenavirus' vs 'none' in 'wild type genotype' | genotype, infect | Comparison of Trail+/+ versus Trail-/- splenic NK cells from naïve and LCMV-infected mice |
-6.3 | | Oasl2 | 'plasmacytoid dendritic cell; Ifnar1 knock out; specific pathogen free' vs 'plasmacytoid dendritic cell; wild type genotype; specific pathogen free' | cell type, genotype, growth condition | RNA sequencing of primary isolated unstimulated murine splenic DC1 and DC2 from specific pathogen free (SPF), Germ free (GF) and Interferon alpha/beta receptor 1 (Ifnar) knock out mice |
6 | | Oasl2 | 'West Nile virus; late stage encephalitis' vs 'mock infection' | infect, time | Transcriptomic profiling of the brains of WNV and CHIKV infection-induced encephalitis in young mice after 2, 3 or 5 days post infection |
5.7 | | Oasl2 | 'SMRT shRNA; CpG; 6 hour' vs 'none; none; 0 hour' | RNA interference, stimulus, time | RNA-seq of Control and SMRT KD CD8α+ DCs at 0hr and 6hr CpG stimulation |
5.7 | | Oasl2 | 'cycloheximide and 100 unit per milliliter interferon alpha' vs 'DMSO' | compound | Dissecting primary (translation independent) from secondary (translation dependent) IFN-mediated differential gene expression |
5.6 | | Oasl2 | 'West Nile virus; early stage encephalitis' vs 'mock infection' | infect, time | Transcriptomic profiling of the brains of WNV and CHIKV infection-induced encephalitis in young mice after 2, 3 or 5 days post infection |
5.6 | | Oasl2 | 'Chikungunya virus; late stage encephalitis' vs 'mock infection' | infect, time | Transcriptomic profiling of the brains of WNV and CHIKV infection-induced encephalitis in young mice after 2, 3 or 5 days post infection |
5.5 | | Oasl2 | 'Lymphocytic choriomeningitis mammarenavirus' vs 'none' in 'TRAIL homozygous knock out' | genotype, infect | Comparison of Trail+/+ versus Trail-/- splenic NK cells from naïve and LCMV-infected mice |
5.5 | | Oasl2 | 'SARS coronavirus MA15; 2 day' vs 'mock' in 'WSB/EiJ' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
5.5 | | Oasl2 | 'interferon gamma; 10 nanogram per milliliter and interleukin-22; 10 nanogram per milliliter' vs 'none' | compound | RNAseq of small intestinal organoids from mice treated with the cytokines IFNG, IL-13 and IL-22 for 24 hours |
5.4 | | Oasl2 | 'lipopolysaccharide; 10 nanogram per milliliter' vs 'none' in 'primary cell line; MEF2C/D knockout' | cell line, compound, genotype | Bulk RNA-seq of wild type and MEF2A or MEF2C/D knockout mouse bone marrow macrophages under different stimulation conditions |
5.4 | | Oasl2 | 'CpG; 6 hour' vs 'none; 0 hour' in 'SMRT shRNA' | RNA interference, stimulus, time | RNA-seq of Control and SMRT KD CD8α+ DCs at 0hr and 6hr CpG stimulation |
5.3 | | Oasl2 | 'SARS coronavirus MA15; 2 day' vs 'mock' in 'CAST/EiJ' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
5.3 | | Oasl2 | 'inhibitor of kappaB kinase beta constitutively active-transgenic' vs 'wild type or single transgenic' | genotype | Transcription profiling by array of embryonic mouse heart ventricles with and without cardiomycocyte-specific expression of constitutively active IKK2 |
5.2 | | Oasl2 | 'interferon gamma' vs 'none' | compound, stimulus | RNA-Seq of murine lung endothelial cells stimulated with IFN-gamma and dexamethasone |
5.1 | | Oasl2 | 'interferon gamma' vs 'dexamethasone; 100 nanomolar' | compound, stimulus | RNA-Seq of murine lung endothelial cells stimulated with IFN-gamma and dexamethasone |
5 | | Oasl2 | 'lipopolysaccharide; 10 nanogram per milliliter and prostaglandin E2; 1 micromolar' vs 'none' in 'primary cell line; MEF2C/D knockout' | cell line, compound, genotype | Bulk RNA-seq of wild type and MEF2A or MEF2C/D knockout mouse bone marrow macrophages under different stimulation conditions |
5 | | Oasl2 | 'interferon gamma; 10 nanogram per milliliter and interleukin-13; 10 nanogram per milliliter' vs 'none' | compound | RNAseq of small intestinal organoids from mice treated with the cytokines IFNG, IL-13 and IL-22 for 24 hours |
5 | | Oasl2 | 'Influenza A virus (A/Puerto Rico/8/1934(H1N1)); 2 day' vs 'mock' in 'CAST/EiJ' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
5 | | Oasl2 | 'lipopolysaccharide; 10 nanogram per milliliter' vs 'none' in 'Hoxb8-FL; MEF2A knockout' | cell line, compound, genotype | Bulk RNA-seq of wild type and MEF2A or MEF2C/D knockout mouse bone marrow macrophages under different stimulation conditions |
5 | | Oasl2 | 'dinitrofluorobenzene' vs 'control' in 'Cnr1 -/- /Cnr2 -/-' | compound, genotype | Transcription profiling of mouse Cannabinoid receptor double knockouts (Cnr1 -/- /Cnr2 -/-) in CHS model to investigate cutaneous contact hypersensitivity |
4.9 | | Oasl2 | 'Influenza A virus (A/Puerto Rico/8/1934(H1N1)); 4 day' vs 'mock' in 'WSB/EiJ' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
4.9 | | Oasl2 | 'Influenza A virus' vs 'none' | infect | RNA-seq of mouse alveolar macrophages from control and Influenza A virus infected animals |
4.9 | | Oasl2 | 'TMEV infected' at '98 day' vs 'mock control' at '98 day' | disease, time | Transcription profiling of mouse spinal cord from mock-infected and Theilers murine encephalomyelitis (TME)-virus infected animals - time series |
4.8 | | Oasl2 | 'SARS coronavirus MA15; 4 day' vs 'mock' in 'A/J' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
4.8 | | Oasl2 | 'dinitrofluorobenzene' vs 'control' in 'wild type' | compound, genotype | Transcription profiling of mouse Cannabinoid receptor double knockouts (Cnr1 -/- /Cnr2 -/-) in CHS model to investigate cutaneous contact hypersensitivity |
4.7 | | Oasl2 | 'interferon gamma' vs 'none' in 'dexamethasone; 100 nanomolar' | compound, stimulus | RNA-Seq of murine lung endothelial cells stimulated with IFN-gamma and dexamethasone |
4.7 | | Oasl2 | 'tamoxifen induction at 2 months, wait 3 months' vs 'no tamoxifen induction' in 'luminal cell of prostate epithelium; Nkx3.1-CreERT2 targeted allele' | cell type, genotype, growth condition | Transcription profiling by high throughput sequencing of PIN/tumor lesions from basal or luminal origins at time points at which mice displayed similar histopathological phenotypes |
4.7 | | Oasl2 | 'dexamethasone; 100 nanomolar; interferon gamma' vs 'none' | compound, stimulus | RNA-Seq of murine lung endothelial cells stimulated with IFN-gamma and dexamethasone |
4.7 | | Oasl2 | 'interferon beta' vs 'eGFP control' | genotype | Transcription profiling by microarray of mouse B16F10 cells transduced with cDNAs encoding eGFP control, p19Arf, murine interferon-beta (IF-B) or the combination of p19Arf plus IF-B to study the modulated genes |
4.7 | | Oasl2 | 'TMEV infected' at '42 day' vs 'mock control' at '42 day' | disease, time | Transcription profiling of mouse spinal cord from mock-infected and Theilers murine encephalomyelitis (TME)-virus infected animals - time series |
4.5 | | Oasl2 | 'Influenza A virus (A/Puerto Rico/8/1934(H1N1)); 2 day' vs 'mock' in 'NOD/ShiLtJ' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
4.5 | | Oasl2 | 'Influenza A virus (A/Puerto Rico/8/1934(H1N1)); 2 day' vs 'mock' in 'A/J' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
4.5 | | Oasl2 | 'tamoxifen induction at 2 months, wait 1 months' vs 'no tamoxifen induction' in 'luminal cell of prostate epithelium; Nkx3.1-CreERT2 targeted allele' | cell type, genotype, growth condition | Transcription profiling by high throughput sequencing of PIN/tumor lesions from basal or luminal origins at time points at which mice displayed similar histopathological phenotypes |
-4.5 | | Oasl2 | 'MEF; transduced with MyoD lentivirus' vs 'MEF; control' | cell line, treatment | Genetic and epigenetic determinants of neurogenesis and myogenesis [expression profiling] |
4.5 | | Oasl2 | 'alopecia areata' vs 'normal' | disease | Mouse Spontaneous C3H/HeJ AA Skin |
-4.4 | | Oasl2 | '5 week' vs '1 week' in 'Jak2+/V617F; CRISPR/Cas9 mediated knockout of Dnmt3a' | genotype, time | RNA-seq of Jak2VF LSK cells transduced with Dnmt3a-Cas9-GFP lentivirus vs. emp-Cas9-GFP controls one week and five weeks post methylcellulose plating |
4.3 | | Oasl2 | 'SARS coronavirus MA15; 2 day' vs 'mock' in 'C57BL/6J' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
4.3 | | Oasl2 | 'Plasmodium berghei ANKA' at '6 day' vs 'none' at '0 day' in 'none' | compound, infect, sampling time point | RNA-seq analysis of anti-malarial drug chemotherapy of murine experimental Cerebral Malaria (ECM) |
4.3 | | Oasl2 | 'liver-specific Cnot3 knockout' vs 'wild type' | phenotype | Roles of mRNA decay in liver development |
4.3 | | Oasl2 | 'SARS coronavirus MA15; 2 day' vs 'mock' in 'NOD/ShiLtJ' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
4.3 | | Oasl2 | 'p19Arf and interferon beta' vs 'eGFP control' | genotype | Transcription profiling by microarray of mouse B16F10 cells transduced with cDNAs encoding eGFP control, p19Arf, murine interferon-beta (IF-B) or the combination of p19Arf plus IF-B to study the modulated genes |
4.3 | | Oasl2 | '100 unit per milliliter interferon alpha' vs 'DMSO' | compound | Dissecting primary (translation independent) from secondary (translation dependent) IFN-mediated differential gene expression |
4.3 | | Oasl2 | 'SARS coronavirus MA15' vs 'none' in 'STAT1 -/-' at '5 day' | genotype, infect, time | Transcriptomic analysis of host response to mouse-adapted SARS virus in wild type, STAT1 -/-, and IFNAR1 -/- mouse genetic backgrounds |
4.3 | | Oasl2 | 'neural stem cell' vs 'niche cell' | cell type | Transcription profiling by high throughput sequencing of three populations of primary dentate gyrus cells |
-4.2 | | Oasl2 | 'pkd1 knockout' vs 'wild type' in 'presence of fluid flow' | genotype, stimulus | Transcription profiling by array of mouse kidney epithelial cells from pkd1 knockout and wild type in response to fluid flow |
-4.1 | | Oasl2 | 'artesunate and chloroquine (at same dosage); 30 milligram per kilogram' at '60 day' vs 'none' at '6 day' in 'Plasmodium berghei ANKA' | compound, infect, sampling time point | RNA-seq analysis of anti-malarial drug chemotherapy of murine experimental Cerebral Malaria (ECM) |
4.1 | | Oasl2 | 'Plasmodium berghei ANKA' at '7 day' vs 'none' at '0 day' in 'none' | compound, infect, sampling time point | RNA-seq analysis of anti-malarial drug chemotherapy of murine experimental Cerebral Malaria (ECM) |
4.1 | | Oasl2 | 'Influenza A virus (A/Puerto Rico/8/1934(H1N1)); 4 day' vs 'mock' in 'NOD/ShiLtJ' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
4.1 | | Oasl2 | 'SARS coronavirus MA15; 4 day' vs 'mock' in 'WSB/EiJ' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
4.1 | | Oasl2 | 'SARS coronavirus MA15; 10^4 PFU' vs 'none' at '2 day' | stimulus, time | SM001: SARS CoV MA15 infection of C57Bl/6 mouse model – Data from 4 viral doses at 1, 2, 4 and 7 days post infection. |
4.1 | | Oasl2 | 'dendritic cell; lipopolysaccharide stimulated' vs 'dendritic cell; unstimulated' | cell type, treatment | Gene expression profile of GM-CSF derived bone marrow dendritic cell subsets after LPS stimulation |
4.1 | | Oasl2 | 'SARS coronavirus MA15' vs 'mock' | infect | Host responses contributing to the attenuation of severe acute respiratory syndrome coronaviruses missing E protein domains |
4.1 | | Oasl2 | 'SARS coronavirus MA15 E protein mutant Δ3' vs 'mock' | infect | Host responses contributing to the attenuation of severe acute respiratory syndrome coronaviruses missing E protein domains |
-4 | | Oasl2 | 'artesunate and chloroquine (at same dosage); 30 milligram per kilogram' at '14 day' vs 'none' at '6 day' in 'Plasmodium berghei ANKA' | compound, infect, sampling time point | RNA-seq analysis of anti-malarial drug chemotherapy of murine experimental Cerebral Malaria (ECM) |
4 | | Oasl2 | 'Influenza A virus (A/Puerto Rico/8/1934(H1N1)); 2 day' vs 'mock' in 'WSB/EiJ' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
4 | | Oasl2 | 'tamoxifen induction at 2 months, wait 6 months' vs 'no tamoxifen induction' in 'basal cell of prostate epithelium; CK5-CreERT2 transgenic line' | cell type, genotype, growth condition | Transcription profiling by high throughput sequencing of PIN/tumor lesions from basal or luminal origins at time points at which mice displayed similar histopathological phenotypes |
4 | | Oasl2 | 'SARS coronavirus MA15; 4 day' vs 'mock' in 'CAST/EiJ' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
4 | | Oasl2 | 'Chikungunya virus; early stage encephalitis' vs 'mock infection' | infect, time | Transcriptomic profiling of the brains of WNV and CHIKV infection-induced encephalitis in young mice after 2, 3 or 5 days post infection |
4 | | Oasl2 | 'lipopolysaccharide; 10 nanogram per milliliter and prostaglandin E2; 1 micromolar and interferon beta; 100 units per milliliter' vs 'none' in 'primary cell line; wild type genotype' | cell line, compound, genotype | Bulk RNA-seq of wild type and MEF2A or MEF2C/D knockout mouse bone marrow macrophages under different stimulation conditions |
4 | | Oasl2 | 'SARS coronavirus MA15; 10^3 PFU' vs 'none' at '2 day' | stimulus, time | SM001: SARS CoV MA15 infection of C57Bl/6 mouse model – Data from 4 viral doses at 1, 2, 4 and 7 days post infection. |
4 | | Oasl2 | 'lipid nanoparticle complexed with ribonucleic acid expressing respiratory synctial virus F protein' vs 'phosphate buffered saline' | stimulus | Microarray analysis of mouse whole genome using self-amplifying messenger (SAM) RNA delivered with different formulations compared to controls |
-3.9 | | Oasl2 | 'artesunate and chloroquine (at same dosage); 30 milligram per kilogram' at '60 day' vs 'none' at '7 day' in 'Plasmodium berghei ANKA' | compound, infect, sampling time point | RNA-seq analysis of anti-malarial drug chemotherapy of murine experimental Cerebral Malaria (ECM) |
-3.9 | | Oasl2 | 'LDB1 knock-down with Ldb1 delta 4/5 construct' vs 'control shRNA' | RNA interference | Role of LDB1 in the transition from chromatin looping to transcription activation |
3.9 | | Oasl2 | 'interferon gamma; 10 nanogram per milliliter' vs 'none' | compound | RNAseq of small intestinal organoids from mice treated with the cytokines IFNG, IL-13 and IL-22 for 24 hours |
3.9 | | Oasl2 | 'AZD7507; AZD5069 (at same dosage); 100 milligram per kilogram' vs 'none' | compound | RNA-seq to investigate differentially expressed genes in KPC mouse PDAC treated with CSF-1R small molecule inhibitor AZD7507 and/or the CXCR2 small molecule inhibitor AZD5069 |
3.9 | | Oasl2 | 'SARS coronavirus MA15' vs 'mock' in 'TLR3 knockout' at '2 day' | genotype, infect, time | Mouse lung tissue transcriptome response to a mouse-adapted strain of SARS-CoV in wild type C57BL6/NJ mice and TLR3-/- mice |
3.9 | | Oasl2 | 'SARS coronavirus MA15; 10^5 PFU' vs 'none' at '2 day' | stimulus, time | SM001: SARS CoV MA15 infection of C57Bl/6 mouse model – Data from 4 viral doses at 1, 2, 4 and 7 days post infection. |
3.9 | | Oasl2 | 'SARS coronavirus MA15' vs 'none' at '1 day' | infect, time | SM012 - SARS MA15 wild type, and SARS deltaORF6 mutant virus infections of C57BL6 mice - A time course |
-3.8 | | Oasl2 | 'artesunate and chloroquine (at same dosage); 30 milligram per kilogram' at '14 day' vs 'none' at '7 day' in 'Plasmodium berghei ANKA' | compound, infect, sampling time point | RNA-seq analysis of anti-malarial drug chemotherapy of murine experimental Cerebral Malaria (ECM) |
-3.8 | | Oasl2 | 'artesunate and chloroquine (at same dosage); 30 milligram per kilogram' at '30 day' vs 'none' at '6 day' in 'Plasmodium berghei ANKA' | compound, infect, sampling time point | RNA-seq analysis of anti-malarial drug chemotherapy of murine experimental Cerebral Malaria (ECM) |
3.8 | | Oasl2 | '21 percent oxygen, 37 degree Celsius, no serum' vs 'none' | growth condition | RNA sequencing of native and ex vivo cultured murine tail tendon fascicles |
3.8 | | Oasl2 | 'lipopolysaccharide; 10 nanogram per milliliter' vs 'none' in 'primary cell line; wild type genotype' | cell line, compound, genotype | Bulk RNA-seq of wild type and MEF2A or MEF2C/D knockout mouse bone marrow macrophages under different stimulation conditions |
3.8 | | Oasl2 | 'SARS coronavirus MA15; 2 day' vs 'mock' in '129S1/SvImJ' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
3.8 | | Oasl2 | 'wild type; SARS MA15; 2 day' vs 'wild type; mock' | genotype, infect, time | Infection of wild type and CXCR3 knockout C57BL6/J mice with SARS MA15 |
3.8 | | Oasl2 | 'SARS coronavirus MA15' vs 'none' at '2 day' | infect, time | SM014 - SARS MA15 wild type, and SARS nsp16 mutant virus infections of C57BL6 mice - A time course |
3.8 | | Oasl2 | 'SARS coronavirus MA15 nsp16 -/-' vs 'none' at '2 day' | infect, time | SM014 - SARS MA15 wild type, and SARS nsp16 mutant virus infections of C57BL6 mice - A time course |
3.7 | | Oasl2 | 'artesunate and chloroquine (at same dosage); 30 milligram per kilogram; Plasmodium berghei ANKA; 7 day' vs 'none; none; 0 day' | compound, infect, sampling time point | RNA-seq analysis of anti-malarial drug chemotherapy of murine experimental Cerebral Malaria (ECM) |
3.7 | | Oasl2 | 'tamoxifen induction at 2 months, wait 3 months' vs 'no tamoxifen induction' in 'basal cell of prostate epithelium; CK5-CreERT2 transgenic line' | cell type, genotype, growth condition | Transcription profiling by high throughput sequencing of PIN/tumor lesions from basal or luminal origins at time points at which mice displayed similar histopathological phenotypes |
3.7 | | Oasl2 | 'Influenza A virus (A/Puerto Rico/8/1934(H1N1)); 2 day' vs 'mock' in '129S1/SvImJ' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
3.7 | | Oasl2 | 'SARS coronavirus MA15' vs 'mock' in 'wild type genotype' at '2 day' | genotype, infect, time | Mouse lung tissue transcriptome response to a mouse-adapted strain of SARS-CoV in wild type C57BL6/NJ mice and TLR3-/- mice |
3.7 | | Oasl2 | 'Lactobacillus acidophilus NCFM' vs 'control' | infect | Transcription profiling by array of mouse dendritic cells after infection with Bifidobacterium bifidum and Lactobacillus acidophilus |
3.7 | | Oasl2 | 'TMEV infected' at '196 day' vs 'mock control' at '196 day' | disease, time | Transcription profiling of mouse spinal cord from mock-infected and Theilers murine encephalomyelitis (TME)-virus infected animals - time series |
3.7 | | Oasl2 | 'CXCR3 knockout; SARS MA15; 2 day' vs 'CXCR3 knockout; mock' | genotype, infect, time | Infection of wild type and CXCR3 knockout C57BL6/J mice with SARS MA15 |
3.7 | | Oasl2 | 'B6I1; 301V infected' at '16 week' vs 'B6I1; uninfected' at '16 week' | strain, time, treatment | Transcription profiling of mouse brain infected with prions in eight mouse-prion strain combinations in a systems approach to the study of prion disease |
-3.6 | | Oasl2 | 'artesunate and chloroquine (at same dosage); 30 milligram per kilogram' at '30 day' vs 'none' at '7 day' in 'Plasmodium berghei ANKA' | compound, infect, sampling time point | RNA-seq analysis of anti-malarial drug chemotherapy of murine experimental Cerebral Malaria (ECM) |
3.6 | | Oasl2 | 'SARS coronavirus MA15; 2 day' vs 'mock' in 'PWK/PhJ' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
3.6 | | Oasl2 | 'lipopolysaccharide; 10 nanogram per milliliter and prostaglandin E2; 1 micromolar' vs 'none' in 'primary cell line; wild type genotype' | cell line, compound, genotype | Bulk RNA-seq of wild type and MEF2A or MEF2C/D knockout mouse bone marrow macrophages under different stimulation conditions |
3.6 | | Oasl2 | 'SARS coronavirus MA15' vs 'none' at '2 day' | infect, time | SM012 - SARS MA15 wild type, and SARS deltaORF6 mutant virus infections of C57BL6 mice - A time course |
3.6 | | Oasl2 | 'Usp18 knockout' vs 'wild type' | genotype | Microarray analysis to evaluate the function of USP18 in the mouse CNS |
3.6 | | Oasl2 | '9 day' vs '0 day' | time | Transcription profiling by array of mineralising murine vascular smooth muscle cell cultures over a nine day culture period to identify new regulators of vascular mineralization |
3.5 | | Oasl2 | 'Influenza A virus (A/Puerto Rico/8/1934(H1N1)); 4 day' vs 'mock' in 'A/J' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
3.5 | | Oasl2 | '21 percent oxygen, 37 degree Celsius, 10 percent serum' vs 'none' | growth condition | RNA sequencing of native and ex vivo cultured murine tail tendon fascicles |
-3.5 | | Oasl2 | 'extraembryonic endoderm stem cell; grown in XEN cell medium' vs 'mouse embryonic fibroblast; control' | cell type, growth condition | OSKM induce extraembryonic endoderm stem (iXEN) cells in parallel to iPS cells |
3.5 | | Oasl2 | 'Influenza A virus (A/Puerto Rico/8/1934(H1N1)); 4 day' vs 'mock' in '129S1/SvImJ' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
3.5 | | Oasl2 | 'Plasmodium berghei ANKA; 1st infection' vs 'none; uninfected' | block, clinical history, infect | Transcription profiling by array of brain from mice repeatedly infected with Plasmodium berghei to study infection-induced resistance to experimental cerebral malaria |
3.5 | | Oasl2 | 'Lactobacillus acidophilus NCFM and Bifidobacterium bifidum Z9' vs 'control' | infect | Transcription profiling by array of mouse dendritic cells after infection with Bifidobacterium bifidum and Lactobacillus acidophilus |
3.5 | | Oasl2 | 'SARS coronavirus MA15 dORF6' vs 'none' at '2 day' | infect, time | SM012 - SARS MA15 wild type, and SARS deltaORF6 mutant virus infections of C57BL6 mice - A time course |
-3.5 | | Oasl2 | 'IRF9 knockout' vs 'wild type genotype' | genotype, stimulus, time | Type I interferon-regulated gene expression and signaling in murine mixed glial cells lacking signal transducers and activators of transcription 1or 2 or interferon regulatory factor 9 |
3.5 | | Oasl2 | 'SARS coronavirus MA15' vs 'none' in 'IFNAR1 -/-' at '5 day' | genotype, infect, time | Transcriptomic analysis of host response to mouse-adapted SARS virus in wild type, STAT1 -/-, and IFNAR1 -/- mouse genetic backgrounds |
-3.4 | | Oasl2 | 'LDB1 knock-down with full-length Ldb1 construct' vs 'control shRNA' | RNA interference | Role of LDB1 in the transition from chromatin looping to transcription activation |
3.4 | | Oasl2 | 'Staphylococcus aureus Sanger476; 12 hour' vs 'none; 0 hour' in 'A/J' | infect, strain, time | Gene Expression-Based Classifiers Identify Staphylococcus aureus Infection in Mice and Humans |
3.4 | | Oasl2 | 'Salmonella enterica serovar Typhimurium' vs 'control' in 'derived macrophage from E14 cell line' | clinical information, infect | Gene expression profiles of mouse embryonic stem cell derived macrophages infected with Salmonella typhimurium |
3.4 | | Oasl2 | 'SARS coronavirus MA15 E protein mutant Δ5' vs 'mock' | infect | Host responses contributing to the attenuation of severe acute respiratory syndrome coronaviruses missing E protein domains |
-3.4 | | Oasl2 | 'STAT1 -/-' vs 'wild type genotype' in 'SARS coronavirus MA15' at '2 day' | genotype, infect, time | Transcriptomic analysis of host response to mouse-adapted SARS virus in wild type, STAT1 -/-, and IFNAR1 -/- mouse genetic backgrounds |
3.3 | | Oasl2 | 'Debaryomyces hansenii' at '12 hour' vs 'none' at '0 hour' | stimulus, time | RNA seq of mouse bone marrow derived macrophages treated with Debaryomyces hansenii against untreated controls |
3.3 | | Oasl2 | 'oxidized low density lipoprotein; 25 microgram per milliliter' vs 'none' in 'wild type genotype' | compound, genotype | Quantitative analysis of wild type and cd36-/- murine peritoneal macrophage transcriptomes |
3.3 | | Oasl2 | 'Influenza A virus (A/Puerto Rico/8/1934(H1N1)); 4 day' vs 'mock' in 'C57BL/6J' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
3.3 | | Oasl2 | 'Mycobacterium tuberculosis; DBA/2J congenic; 30 day' vs 'control; DBA/2J congenic; 0 day' | infect, strain, time | Transcription profiling of mouse lung from C57BL6 and DBA2 parental strains and D2.B6-Chr7 and D2.B6-Chr19 congenic mice following aerosol infection with Mycobacterium tuberculosis for 30 and 70 days |
3.3 | | Oasl2 | 'viral replicon particle expressing respiratory synctial virus F protein' vs 'phosphate buffered saline' | stimulus | Microarray analysis of mouse whole genome using self-amplifying messenger (SAM) RNA delivered with different formulations compared to controls |
3.2 | | Oasl2 | 'Helicobacter hepaticus' vs 'none' in 'Alpk1 homozygous knockout' | infect, phenotype | Whole transcriptome profiling of the steady state and Hh-treated (8 hrs) Alpk1+/- (heterozygous) and Alpk1-/- (knockout) BMDMs using RNA-Sequencing approach |
3.2 | | Oasl2 | 'poly(I:C)' vs 'none' | stimulus | 3’-Seq of ex vivo isolated mouse multipotent steady state hematopoietic stem cells (sHSC) and proliferating HSCs |
3.2 | | Oasl2 | 'SARS coronavirus MA15; 10^3 PFU' vs 'none' at '4 day' | stimulus, time | SM001: SARS CoV MA15 infection of C57Bl/6 mouse model – Data from 4 viral doses at 1, 2, 4 and 7 days post infection. |
3.2 | | Oasl2 | 'interferon alpha' vs 'none' | compound | Type I and II Interferon-Stimulated Genes in Murine Primary Bone Marrow Macrophages |
3.2 | | Oasl2 | 'Mycobacterium tuberculosis; D2.B6-Chr19 congenic; 70 day' vs 'control; D2.B6-Chr19 congenic; 0 day' | infect, strain, time | Transcription profiling of mouse lung from C57BL6 and DBA2 parental strains and D2.B6-Chr7 and D2.B6-Chr19 congenic mice following aerosol infection with Mycobacterium tuberculosis for 30 and 70 days |
3.2 | | Oasl2 | 'conditional Kras and p53 mutation induced soft tissue sarcoma' vs 'normal' | disease | Transcription profiling by array of mouse soft tissue sarcoma samples induced by conditional mutations of Kras and p53 against healthy muscles from mice of the same genotype but no induced sarcoma |
-3.2 | | Oasl2 | 'heat-shocked at 42 degreeC' vs 'grown at 33 degreeC' in 'HdhQ111 knock-in' | genotype, growth condition | Transcription profiling by array of mouse wild type and Htt mutant striatal cells upon heat shock |
3.2 | | Oasl2 | 'malignant peritoneal mesothelioma; hi SV40 virus large TAg genotype (hiTAg)' vs 'malignant peritoneal mesothelioma; wild type genotype' | disease, genotype | Gene expression profiles in MexTAg transgenic mouse and wild type mouse asbestos-induced mesothelioma |
3.1 | | Oasl2 | 'Salmonella enterica serovar Typhimurium' vs 'control' in 'bone marrow macrophage from 129P2 mouse strain' | clinical information, infect | Gene expression profiles of mouse embryonic stem cell derived macrophages infected with Salmonella typhimurium |
3.1 | | Oasl2 | 'Debaryomyces hansenii' at '24 hour' vs 'none' at '0 hour' | stimulus, time | RNA seq of mouse bone marrow derived macrophages treated with Debaryomyces hansenii against untreated controls |
3.1 | | Oasl2 | 'oxidized low density lipoprotein; 25 microgram per milliliter' vs 'none' in 'CD36 knockout' | compound, genotype | Quantitative analysis of wild type and cd36-/- murine peritoneal macrophage transcriptomes |
3.1 | | Oasl2 | 'SARS coronavirus MA15; 4 day' vs 'mock' in 'PWK/PhJ' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
3.1 | | Oasl2 | 'trans-tympanically injected with Hemophilus influenza' vs 'control' | treatment | Otitis Media Impact on Middle Ear |
-3.1 | | Oasl2 | 'conventional dendritic cell; Ifnar1 knock out; specific pathogen free' vs 'conventional dendritic cell; wild type genotype; specific pathogen free' | cell type, genotype, growth condition | RNA sequencing of primary isolated unstimulated murine splenic DC1 and DC2 from specific pathogen free (SPF), Germ free (GF) and Interferon alpha/beta receptor 1 (Ifnar) knock out mice |
3.1 | | Oasl2 | 'hepatocyte-derived proliferative ducts (hepPDs)' vs 'hepatocyte' | cell type | Transcription profiling by high throughput sequencing of hepatocyte-derived progenitors cells in a mouse model of oval cell activation |
3.1 | | Oasl2 | 'Bifidobacterium bifidum Z9' vs 'control' | infect | Transcription profiling by array of mouse dendritic cells after infection with Bifidobacterium bifidum and Lactobacillus acidophilus |
3.1 | | Oasl2 | 'Foxd3 knockout' vs 'control' | phenotype | Expression data from embryonic stem cells differentiation |
3.1 | | Oasl2 | 'glioblastoma multiforme' vs 'normal' | disease | Analysis of the expression profiles of glioma-associated microglia/macrophages and naive control cells in Mus musculus. |
3.1 | | Oasl2 | 'Mycobacterium tuberculosis; DBA/2J congenic; 70 day' vs 'control; DBA/2J congenic; 0 day' | infect, strain, time | Transcription profiling of mouse lung from C57BL6 and DBA2 parental strains and D2.B6-Chr7 and D2.B6-Chr19 congenic mice following aerosol infection with Mycobacterium tuberculosis for 30 and 70 days |
3.1 | | Oasl2 | 'human chorionic gonadotropin; 5 International Unit' vs 'none' in 'bER knockout' | compound, genotype | Laser Capture Microdissection isolation of preovulatory granulosa cells from WT and bERKO ovaries |
3 | | Oasl2 | 'SARS coronavirus MA15; 4 day' vs 'mock' in 'NOD/ShiLtJ' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
3 | | Oasl2 | 'colitis' at '19 day' vs 'normal' at '0 day' | disease, time | Temporal transcriptomic changes during DSS colitis development and resolution. |
3 | | Oasl2 | 'Sall1 deficient microglia' vs 'wild type microglia' | genotype, phenotype | RNA sequencing of microglia sorted form tamoxifen treated Sall1CreER/fl and control Sall1fl/fl mice |
3 | | Oasl2 | 'Escherichia coli O18:K1:H7; 12 hour' vs 'none; 0 hour' in 'A/J' | infect, strain, time | Gene Expression-Based Classifiers Identify Staphylococcus aureus Infection in Mice and Humans |
-3 | | Oasl2 | 'inhibition of BRD4 with JQ1' vs 'DMSO' | treatment | Expression Data For BRD4 Inhibition |
-3 | | Oasl2 | 'PFI-1; 10 nanogram per milliliter' vs 'none' in 'primary cell line; wild type genotype' | cell line, compound, genotype | Bulk RNA-seq of wild type and MEF2A or MEF2C/D knockout mouse bone marrow macrophages under different stimulation conditions |
3 | | Oasl2 | 'lipopolysaccharide; 10 nanogram per milliliter' vs 'none' in 'Hoxb8-FL; wild type genotype' | cell line, compound, genotype | Bulk RNA-seq of wild type and MEF2A or MEF2C/D knockout mouse bone marrow macrophages under different stimulation conditions |
3 | | Oasl2 | 'Tfc knockout; normal' vs 'control' | disease, genotype | Gene expression in thymi of Tcf1 -/-, Tcf +/- or Tcf1 -/- mice with tumor. |
3 | | Oasl2 | 'colitis' at '8 day' vs 'normal' at '0 day' | disease, time | Temporal transcriptomic changes during DSS colitis development and resolution. |
-3 | | Oasl2 | 'pkd1 knockout' vs 'wild type' in 'absence of fluid flow' | genotype, stimulus | Transcription profiling by array of mouse kidney epithelial cells from pkd1 knockout and wild type in response to fluid flow |
2.9 | | Oasl2 | 'adipose tissue specific Cnot1 knockout' vs 'wild type phenotype' in 'brown adipose tissue' | organism part, phenotype | RNA-seq to identify the role of mRNA decay in mouse adipose tissues |
2.9 | | Oasl2 | 'CpG; 6 hour' vs 'none; 0 hour' in 'none' | RNA interference, stimulus, time | RNA-seq of Control and SMRT KD CD8α+ DCs at 0hr and 6hr CpG stimulation |
-2.9 | | Oasl2 | 'MEF2A knockout' vs 'wild type genotype' in 'Hoxb8-FL; none' | cell line, compound, genotype | Bulk RNA-seq of wild type and MEF2A or MEF2C/D knockout mouse bone marrow macrophages under different stimulation conditions |
2.9 | | Oasl2 | 'interferon beta' vs 'none' in 'wild type; uninfected' | compound, disease, genotype | Transcription profiling of mouse influenza virus infected in wild type and mutant animals revels induced gene expression changes of regional B cells are mediated in part through type I IFN |
2.9 | | Oasl2 | 'Influenza A virus' vs 'mock' in 'IgG1' | infect, stimulus | Transcription profiling by array of pulmonary gene expression in response to interleukin-22 during severe influenza |
2.9 | | Oasl2 | 'SARS coronavirus MA15; 10^4 PFU' vs 'none' at '4 day' | stimulus, time | SM001: SARS CoV MA15 infection of C57Bl/6 mouse model – Data from 4 viral doses at 1, 2, 4 and 7 days post infection. |
2.9 | | Oasl2 | 'SARS coronavirus MA15 dORF6' vs 'none' at '1 day' | infect, time | SM012 - SARS MA15 wild type, and SARS deltaORF6 mutant virus infections of C57BL6 mice - A time course |
2.9 | | Oasl2 | 'B6I1; 301V infected' at '18 week' vs 'B6I1; uninfected' at '18 week' | strain, time, treatment | Transcription profiling of mouse brain infected with prions in eight mouse-prion strain combinations in a systems approach to the study of prion disease |
2.9 | | Oasl2 | 'cecal ligation and puncture surgery; PPTA knockout' vs 'cecal ligation and puncture surgery; wild type' | clinical treatment, genotype | Gene expression profile in lung tissue 8 h after inducing polymicrobial sepsis in preprotachykinin-A (PPTA) knockout mice and wild type |
2.8 | | Oasl2 | 'SARS coronavirus MA15; 4 day' vs 'mock' in 'C57BL/6J' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
2.8 | | Oasl2 | 'Duchenne muscular dystrophy' vs 'normal' | disease | RNA-seq comparison of immortalised myoblasts from dystrophic and WT mice |
-2.8 | | Oasl2 | 'dexamethasone (1 μM) and GW7647 (0.5 μM)' vs 'none' | compound | RNA-seq of primary hepatocytes treated with GR and PPARalpha agonists in the presence of LPS |
2.8 | | Oasl2 | 'doxycycline; 200 nanogram per milliliter; neoplasm; 12 day' vs 'none; normal; 0 day' | compound, phenotype, time | RNA-seq of doxycycline induced tumor and residual mouse primary mammary epithelial cells grown in 3D cell cultures against non-induced controls |
-2.8 | | Oasl2 | 'acute graft vs. host disease; T-cell depleted bone marrow + T cells transplant' vs 'normal; T-cell depleted bone marrow transplant' | disease, stimulus | RNA-Seq of lymph node fibroblastic reticular cells isolated from bone marrow transplant recipient mice with or without acute Graft-versus-host disease on day 7 or untransplanted control mice |
2.8 | | Oasl2 | 'Escherichia coli O18:K1:H7; 24 hour' vs 'none; 0 hour' in 'A/J' | infect, strain, time | Gene Expression-Based Classifiers Identify Staphylococcus aureus Infection in Mice and Humans |
2.8 | | Oasl2 | 'wild type genotype; SARS MA15; 4 day' vs 'wild type genotype; mock' | genotype, infect, time | SARS infection of C57BL6, TIMP1 and Serpine1 knock-out mice |
2.8 | | Oasl2 | 'SMRT shRNA' vs 'none' in 'CpG' at '6 hour' | RNA interference, stimulus, time | RNA-seq of Control and SMRT KD CD8α+ DCs at 0hr and 6hr CpG stimulation |
-2.8 | | Oasl2 | 'myeloid lineage restricted progenitor cell' vs 'long term hematopoietic stem cell' in 'Elp3fl/fl' | cell type, genotype | RNA-seq of long-term hematopoietic stem cells and myeloid progenitors of control mice or mice conditionally deficient for Trp53 or Elp3 or both genes in the hematopoietic system |
2.8 | | Oasl2 | 'cycloheximide and 100 unit per milliliter interferon gamma' vs 'DMSO' | compound | Dissecting primary (translation independent) from secondary (translation dependent) IFN-mediated differential gene expression |
2.8 | | Oasl2 | 'SARS coronavirus MA15' vs 'none' in 'wild type genotype' at '4 day' | genotype, infect, time | SM019 - Infection with SARS MA15 of C57BL/6J mice and Tnfrsf1b knockout mice |
2.8 | | Oasl2 | 'UV' vs 'sham' in 'DMSO' at '6 hour' | irradiate, time | Transcription profiling by array of mouse dorsal skin exposed to UV radiation vs controls in mice treated with DMSO or selective tyrosine kinase inhibitor AG825 |
-2.8 | | Oasl2 | 'IFNR null' vs 'wild type' in 'influenza infected' | compound, disease, genotype | Transcription profiling of mouse influenza virus infected in wild type and mutant animals revels induced gene expression changes of regional B cells are mediated in part through type I IFN |
2.8 | | Oasl2 | 'SARS coronavirus MA15 lacking full-length E protein' vs 'mock' | infect | Host responses contributing to the attenuation of severe acute respiratory syndrome coronaviruses missing E protein domains |
-2.7 | | Oasl2 | 'dexamethasone; 1 micromolar' vs 'none' | compound | RNA-seq of primary hepatocytes treated with GR and PPARalpha agonists in the presence of LPS |
-2.7 | | Oasl2 | 'MEF2A knockout' vs 'wild type genotype' in 'Hoxb8-FL; lipopolysaccharide; 10 nanogram per milliliter' | cell line, compound, genotype | Bulk RNA-seq of wild type and MEF2A or MEF2C/D knockout mouse bone marrow macrophages under different stimulation conditions |
2.7 | | Oasl2 | 'Escherichia coli O18:K1:H7; 6 hour' vs 'none; 0 hour' in 'A/J' | infect, strain, time | Gene Expression-Based Classifiers Identify Staphylococcus aureus Infection in Mice and Humans |
2.7 | | Oasl2 | 'TGFβ, 5 nanogram per milliliter' vs 'none' | sampling site, stimulus | Cellular and extracellular vesicle RNA sequence for E-cadherin-RFP EMT reporter system expressing mouse breast cancer cell line Py2T during EMT/MET |
2.7 | | Oasl2 | 'Influenza A virus' vs 'mock' in 'interleukin-22' | infect, stimulus | Transcription profiling by array of pulmonary gene expression in response to interleukin-22 during severe influenza |
-2.7 | | Oasl2 | 'acute myeloid leukemia' vs 'myeloproliferative disorder' | disease | Transcription profiling by high throughput sequencing of c-KIT+ splenocytes from murine acute myeloid leukemia and myeloproliferative neoplasm |
2.7 | | Oasl2 | 'Mycobacterium tuberculosis; D2.B6-Chr7 congenic; 70 day' vs 'control; D2.B6-Chr7 congenic; 0 day' | infect, strain, time | Transcription profiling of mouse lung from C57BL6 and DBA2 parental strains and D2.B6-Chr7 and D2.B6-Chr19 congenic mice following aerosol infection with Mycobacterium tuberculosis for 30 and 70 days |
2.7 | | Oasl2 | 'P60; insulin-expressing mature beta cells' vs 'E16.5; insulin-expressing nascent beta cells' | age, cell type | Transcriptional profiling of nascent and mature pancreatic beta cells |
2.7 | | Oasl2 | 'SARS coronavirus MA15; 10^5 PFU' vs 'none' at '4 day' | stimulus, time | SM001: SARS CoV MA15 infection of C57Bl/6 mouse model – Data from 4 viral doses at 1, 2, 4 and 7 days post infection. |
2.7 | | Oasl2 | 'influenza' vs 'uninfected' in 'wild type' | compound, disease, genotype | Transcription profiling of mouse influenza virus infected in wild type and mutant animals revels induced gene expression changes of regional B cells are mediated in part through type I IFN |
2.7 | | Oasl2 | 'MOG35-55' vs 'none' at '20 day' | compound, time | Transcriptomic profiling in the animal model of multiple sclerosis |
2.7 | | Oasl2 | 'TMEV infected' at '14 day' vs 'mock control' at '14 day' | disease, time | Transcription profiling of mouse spinal cord from mock-infected and Theilers murine encephalomyelitis (TME)-virus infected animals - time series |
2.7 | | Oasl2 | 'SARS coronavirus MA15 dORF6' vs 'none' at '4 day' | infect, time | SM012 - SARS MA15 wild type, and SARS deltaORF6 mutant virus infections of C57BL6 mice - A time course |
2.7 | | Oasl2 | 'Influenza A virus (A/Scotland/20/1974(H3N2))' vs 'none' | infect | RNA-seq of mouse colon to investigate how influenza infection leads to intestinal disorders |
-2.7 | | Oasl2 | 'doxycycline-induced inactivation of ErbB3' vs 'ErbB3 expression' | phenotype | Transcription profiling by array of mouse mammary epithelial organoids after doxycyline-induced repression of ErbB3 expression |
2.6 | | Oasl2 | 'lipopolysaccharide' vs 'none' in 'bone marrow; wild type' | cell type, compound, genotype | Transcription profiling by high throughput sequencing of spleens of GPR34 knockout and wild type mice |
-2.6 | | Oasl2 | 'diphtheria toxin; 30 nanogram per gram' vs 'none' | stimulus | RNA-seq of mouse brain tissue repopulating microglia in response to traumatic brain injury |
2.6 | | Oasl2 | 'interleukin-22 (Mus Musculus); 10 nanogram per milliliter' vs 'none' | compound | RNAseq of small intestinal organoids from mice treated with the cytokines IFNG, IL-13 and IL-22 for 24 hours |
2.6 | | Oasl2 | 'colitis' at '12 day' vs 'normal' at '0 day' | disease, time | Temporal transcriptomic changes during DSS colitis development and resolution. |
2.6 | | Oasl2 | 'Influenza A virus (A/Puerto Rico/8/1934(H1N1)); 4 day' vs 'mock' in 'PWK/PhJ' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
2.6 | | Oasl2 | 'Mycobacterium tuberculosis; C57BL/6J; 30 day' vs 'control; C57BL/6J; 0 day' | infect, strain, time | Transcription profiling of mouse lung from C57BL6 and DBA2 parental strains and D2.B6-Chr7 and D2.B6-Chr19 congenic mice following aerosol infection with Mycobacterium tuberculosis for 30 and 70 days |
2.6 | | Oasl2 | 'PAI1 knockout; SARS MA15; 4 day' vs 'PAI1 knockout; mock' | genotype, infect, time | SARS infection of C57BL6, TIMP1 and Serpine1 knock-out mice |
2.6 | | Oasl2 | 'Lkb1 -/- Pten-/-' vs 'wild type' | genotype | Loss of Lkb1 and Pten Leads to Lung Squamous Cell Carcinoma with Elevated Pdl1 Expression: Epithelial Cells |
2.6 | | Oasl2 | 'lymphocytic choriomeningitis virus WE' vs 'normal' | disease | Transcription profiling by array of lymphocytic choriomeningitis virus-strain WE (LCMV-WE) infected mice versus naive mice. |
2.6 | | Oasl2 | 'status epilepticus' vs 'none' in 'microglia; soticlestat; 30 milligram per kilogram' | cell type, compound, disease | RNA-seq profiling of three distinct cell populations in a murine model of epilepsia with and without drug treatment |
-2.6 | | Oasl2 | 'undifferentiated' vs 'differentiated; rosiglitazone' in '129S6sv/ev' | phenotype, stimulus, strain | RNA-seq of mouse subcutaneous SVF cells before and after differentiation with a brown fat differentiation cocktail |
2.6 | | Oasl2 | 'liver-specific Gp130 knockout mice [Gp130delta(hepa)]; cecal ligation and puncture' vs 'liver-specific Gp130 knockout mice [Gp130delta(hepa)]; control' | genotype, treatment | Hepatic acute phase proteins control innate immune responses during infection by promoting myeloid derived suppressor cell function |
-2.5 | | Oasl2 | 'artesunate and chloroquine (at same dosage); 30 milligram per kilogram' at '10 day' vs 'none' at '6 day' in 'Plasmodium berghei ANKA' | compound, infect, sampling time point | RNA-seq analysis of anti-malarial drug chemotherapy of murine experimental Cerebral Malaria (ECM) |
2.5 | | Oasl2 | 'Triple knockout (Zfp36-/-, TNFR1-/-, TNFR2-/-)' vs 'wild type' | genotype | Transcription profiling by high throughput sequencing of douple (TNFR1-/-/TNFR2-/-) and triple (Zfp36-/-/TNFR1-/-/TNFR2-/-) knockout mouse spleens |
2.5 | | Oasl2 | 'liver-specific Cnot1 knockout' vs 'wild type' | phenotype | Roles of mRNA decay in liver development |
2.5 | | Oasl2 | 'Alb-Cre-ERT2 / Cnot1 flox/flox' vs 'Cnot1 flox/flox' in 'none' | compound, genotype, time | RNA-seq of livers in control and Cnot1 tamoxifen-inducible liver-specific knockout mice |
2.5 | | Oasl2 | 'hematopoietic stem cell and hematopoietic multipotent progenitor cell' vs 'common myeloid progenitor' | cell type | Transcription profiling by high throughput sequencing between multipotent hematopoietic stem progenitor cells LS+K) and myeloid committed cells (LS−K) of the mouse bone marrow |
2.5 | | Oasl2 | 'SARS coronavirus MA15' vs 'mock' in 'wild type genotype' at '4 day' | genotype, infect, time | Mouse lung tissue transcriptome response to a mouse-adapted strain of SARS-CoV in wild type C57BL6/NJ mice and TLR3-/- mice |
2.5 | | Oasl2 | 'proliferating progenitor' vs 'differentiating progenitor' | cell type | Transcription profiling by high throughput sequencing of proliferating neural stem cells, differentiating neurogenic progenitors and newborn neurons using a dual-reporter mouse line |
2.5 | | Oasl2 | 'Mycobacterium tuberculosis; D2.B6-Chr19 congenic; 30 day' vs 'control; D2.B6-Chr19 congenic; 0 day' | infect, strain, time | Transcription profiling of mouse lung from C57BL6 and DBA2 parental strains and D2.B6-Chr7 and D2.B6-Chr19 congenic mice following aerosol infection with Mycobacterium tuberculosis for 30 and 70 days |
2.5 | | Oasl2 | 'SARS coronavirus MA15' vs 'mock' in 'TLR3 knockout' at '4 day' | genotype, infect, time | Mouse lung tissue transcriptome response to a mouse-adapted strain of SARS-CoV in wild type C57BL6/NJ mice and TLR3-/- mice |
2.5 | | Oasl2 | 'Chlamydia pneumoniae' vs 'mock' in 'wild type' | genotype, infect | Transcription profiling of lungs from wild type and MyD88 knockout mice infected with Chlamydia pneumoniae to explore the influence of MyD88 on induction of immune responses. |
2.5 | | Oasl2 | 'PTEN null' vs 'wild type genotype' | genotype | RNA seq of prostate gland from WT, PTEN pc -/- and PTEN pc-/-;P53 -/- mice |
2.5 | | Oasl2 | 'Dicer knockout' vs 'wild type genotype' | genotype | Transcription profiling by array of mouse Dicer-knockout CD4 T cells against wild type controls |
-2.5 | | Oasl2 | 'Pcl2 knockdown' vs 'control' | genotype | Gene expression profile in mouse embryonic stem cells in which endogenous Pcl2 expression was stably knocked down using short hairpin RNA |
2.5 | | Oasl2 | '19BL; undifferentiated 3factor-reprogrammed induced pluripotent stem cell' vs 'R1; undifferentiated embryonic stem cell' at '0 day' | cell line, growth condition, time | Natural cardiogenesis-based template predicts cardiogenic potential of induced pluripotent stem cell lines |
2.5 | | Oasl2 | 'chemical hypoxia' vs 'control' | growth condition | Comparison of gene expression in whole blood of mice subjected to chemical hypoxia in vivo. |
2.5 | | Oasl2 | 'SARS coronavirus MA15' vs 'none' in 'wild type genotype' at '5 day' | genotype, infect, time | Transcriptomic analysis of host response to mouse-adapted SARS virus in wild type, STAT1 -/-, and IFNAR1 -/- mouse genetic backgrounds |
2.5 | | Oasl2 | 'inhibitor of kappaB kinase beta constitutively active' vs 'wild type' | phenotype | Transcription profiling by array of primary murine cardiomyocytes with and without expression of constitutively active IKK2 |
-2.5 | | Oasl2 | 'STAT1 -/-' vs 'wild type genotype' in 'none' at '5 day' | genotype, infect, time | Transcriptomic analysis of host response to mouse-adapted SARS virus in wild type, STAT1 -/-, and IFNAR1 -/- mouse genetic backgrounds |
2.5 | | Oasl2 | 'SARS coronavirus MA15; 10^2 PFU' vs 'none' at '4 day' | stimulus, time | SM001: SARS CoV MA15 infection of C57Bl/6 mouse model – Data from 4 viral doses at 1, 2, 4 and 7 days post infection. |
2.4 | | Oasl2 | 'Debaryomyces hansenii' at '6 hour' vs 'none' at '0 hour' | stimulus, time | RNA seq of mouse bone marrow derived macrophages treated with Debaryomyces hansenii against untreated controls |
2.4 | | Oasl2 | 'Irgm1 knockout' vs 'wild type genotype' in 'brain' | genotype, organism part | RNA-Seq of bone marrow derived macophages (BMDMs) and brain tissue isolated from wild type and Irgm1 knockout mice |
-2.4 | | Oasl2 | 'artesunate and chloroquine (at same dosage); 30 milligram per kilogram' at '10 day' vs 'none' at '7 day' in 'Plasmodium berghei ANKA' | compound, infect, sampling time point | RNA-seq analysis of anti-malarial drug chemotherapy of murine experimental Cerebral Malaria (ECM) |
2.4 | | Oasl2 | 'postnatal day 60' vs 'postnatal day 1' in 'insulin-expressing immature beta cell' | cell type, developmental stage | Transcription profiling by high throughput sequencing of murine beta cells at key stages of maturation |
2.4 | | Oasl2 | 'interleukin-13 (Mus musculus); 10 nanogram per milliliter' vs 'none' | compound | RNAseq of small intestinal organoids from mice treated with the cytokines IFNG, IL-13 and IL-22 for 24 hours |
-2.4 | | Oasl2 | 'induced extraembryonic endoderm stem cell; grown in ES cell medium' vs 'mouse embryonic fibroblast; control' | cell type, growth condition | OSKM induce extraembryonic endoderm stem (iXEN) cells in parallel to iPS cells |
2.4 | | Oasl2 | 'intestinal smooth muscle culture supernatant' vs 'none' in 'organoid culture without Noggin (ER medium)' | growth condition, stimulus | RNA-seq of small intestinal organoids treated with the control medium ENR (EGF, Noggin, R-spondin1) in the presence or absence of muscle supernatant |
2.4 | | Oasl2 | 'wild type genotype; SARS MA15; 7 day' vs 'wild type genotype; mock' | genotype, infect, time | SARS infection of C57BL6, TIMP1 and Serpine1 knock-out mice |
2.4 | | Oasl2 | 'Mycobacterium tuberculosis H37Rv' vs 'none' in 'TNF-alpha knockout' | compound, genotype, infect | 4-week mouse comparative study on effect of neutralizing IL-17A, IL-17F and TNFa antibodies |
-2.4 | | Oasl2 | 'Gprc5a knockout' vs 'control' | genotype | Gene expression profile of lung epithelial cells cultured from normal tracheas of Gprc5a knockout and wild-type mice |
2.4 | | Oasl2 | 'Mycobacterium tuberculosis; C57BL/6J; 70 day' vs 'control; C57BL/6J; 0 day' | infect, strain, time | Transcription profiling of mouse lung from C57BL6 and DBA2 parental strains and D2.B6-Chr7 and D2.B6-Chr19 congenic mice following aerosol infection with Mycobacterium tuberculosis for 30 and 70 days |
2.4 | | Oasl2 | '30 days of tuberculosis' vs 'uninfected' | disease, time | Transcription profiling by array of lungs from mice infected with tuberculosis |
2.4 | | Oasl2 | '100 unit per milliliter interferon gamma' vs 'DMSO' | compound | Dissecting primary (translation independent) from secondary (translation dependent) IFN-mediated differential gene expression |
2.4 | | Oasl2 | 'Mycobacterium tuberculosis; D2.B6-Chr7 congenic; 30 day' vs 'control; D2.B6-Chr7 congenic; 0 day' | infect, strain, time | Transcription profiling of mouse lung from C57BL6 and DBA2 parental strains and D2.B6-Chr7 and D2.B6-Chr19 congenic mice following aerosol infection with Mycobacterium tuberculosis for 30 and 70 days |
2.4 | | Oasl2 | 'wild type genotype; SARS MA15; 4 day' vs 'wild type genotype; mock' | genotype, infect, time | SARS infection of C57BL6, and PLAT knock-out mice |
2.4 | | Oasl2 | 'SARS coronavirus MA15' vs 'none' in 'Tnfrsf1a/1b -/-' at '4 day' | genotype, infect, time | SM019 - Infection with SARS MA15 of C57BL/6J mice and Tnfrsf1b knockout mice |
2.4 | | Oasl2 | 'R6/2 transgenic' vs 'wild type' in '12 week; striatum' | age, genotype, organism part | Transcription profiling by high throughput sequencing in wild type and R6/2 mutant mouse cortex and striatum at 8 and 12 weeks. |
-2.4 | | Oasl2 | 'renin-expression' vs 'control' | phenotype | Expression data from mouse bone marrow cells expressing renin driven expression of green fluorescent protein. |
2.4 | | Oasl2 | 'TIMP1 knockout; SARS MA15; 4 day' vs 'TIMP1 knockout; mock' | genotype, infect, time | SARS infection of C57BL6, TIMP1 and Serpine1 knock-out mice |
-2.4 | | Oasl2 | 'Irx3 knockout' vs 'control' at '1 day' | genetic modification, time | RNA-Seq of mouse Irx3-KO and Control ME3 cells on days 1 and 7 of adipogenic differentiation |
-2.4 | | Oasl2 | 'UNC0638' vs 'control' | compound | G9a-dependent gene expression in mouse AML cells |
-2.4 | | Oasl2 | 'Cbs knockout' vs 'wild type' | genotype | Gene expression profile of CD4-positive T cells from mouse Cbs knockout |
-2.4 | | Oasl2 | 'uterine-specific Tsc2-null' vs 'wild type' in 'intact' | genotype, treatment | Transcription profiling by high throughput sequencing of uterine-specific Tsc2-null mice |
2.4 | | Oasl2 | 'Runx3 knockout' vs 'wild type genotype' in 'IL-2' | compound, genotype | Runx3 function in splenic NK cells (IL-2 or IL-15) |
2.3 | | Oasl2 | 'clear cell sarcoma; TATCre' vs 'control' | disease, genotype | Mouse Model of Clear Cell Sarcoma |
2.3 | | Oasl2 | 'polarized with E coli lipopolysacharide and INF-gamma' vs 'untreated' | compound, treatment | Expression data from polarized macrophages: effect of p53 |
2.3 | | Oasl2 | 'seizure-preconditioning followed by intra-amygdala kainic acid' vs 'sham-preconditioning followed by intra-amygdala vehicle' | clinical treatment | Transcription profiling by array of mice with epileptic tolerance |
2.3 | | Oasl2 | 'SARS coronavirus MA15' vs 'none' at '4 day' | infect, time | SM014 - SARS MA15 wild type, and SARS nsp16 mutant virus infections of C57BL6 mice - A time course |
2.3 | | Oasl2 | 'PAI1 knockout; SARS MA15; 7 day' vs 'PAI1 knockout; mock' | genotype, infect, time | SARS infection of C57BL6, TIMP1 and Serpine1 knock-out mice |
-2.3 | | Oasl2 | 'recombinant growth differentiation factor 11; 100 nanogram per milliliter' vs 'vehicle' | compound | Transcription profiling by array of mouse bone marrow-derived macrophages treated with recombinant growth differentiation factor 11 (rGDF11) |
2.3 | | Oasl2 | 'scrapie ME7 inoculated' at '120 day' vs 'none' at '0 day' | infect, time | Transcription profiling by array of brains from mice infected with scrapie ME7 |
2.3 | | Oasl2 | '70 week' vs '6 week' in 'none; none; | age, irradiate | Pericyte induced reprogramming of the bone marrow microenvironment drives stem and cancer cell quiescence |
-2.3 | | Oasl2 | 'SGC-CBP30; 10 nanogram per milliliter' vs 'none' in 'primary cell line; wild type genotype' | cell line, compound, genotype | Bulk RNA-seq of wild type and MEF2A or MEF2C/D knockout mouse bone marrow macrophages under different stimulation conditions |
2.3 | | Oasl2 | 'SARS coronavirus MA15' vs 'none' at '4 day' | infect, time | SM012 - SARS MA15 wild type, and SARS deltaORF6 mutant virus infections of C57BL6 mice - A time course |
-2.3 | | Oasl2 | 'Fn14 knockout' vs 'wild type' in 'none' | compound, genotype | Chronic TNBS Colitis in the FN14 KO Mouse |
2.3 | | Oasl2 | 'untreated; Csf2rb-/-' vs 'untreated; wild type' | clinical history, genotype | Mouse GM-CSF-related alveolar macrophage genome-wide expression data |
2.2 | | Oasl2 | 'Mif knockout' vs 'wild type genotype' | genotype | Role of Macrophage migration inhibitory factor (MIF) in pancreatic stellate cells (PSCs) |
-2.2 | | Oasl2 | 'Mef2c deletion' vs 'wild type' | phenotype | Whole transcriptome sequencing of mouse regulatory T cells with and without Mef2d, Mef2c, HDAC1, HDAC2 or Dyrk1 deletion |
-2.2 | | Oasl2 | 'miR-155 knockout' vs 'wild type' in 'natural killer cell' | cell type, genotype | Context- and cell-type specific function of miR155-Socs1 interaction in immune regulation |
2.2 | | Oasl2 | 'chronic pancreatitis' vs 'control' | disease | Pancreatic gene expression associated with cerulein induced chronic pancreatitis in mice |
2.2 | | Oasl2 | '5XFAD transgenic' vs 'wild type' | genotype | Transcription profiling by array of microglia purified from wild type and TREM2 deficient microglia in a mouse model of Alzheimer's disease |
2.2 | | Oasl2 | 'Tgfbeta inhibitor 20 micromolar' vs 'none' | compound | Expression data from intestinal organoids altered for Tgfbeta signaling |
2.2 | | Oasl2 | '2 day' vs '1 day' in 'influenza A infected C57BL/6J' | disease, strain, time | Transcription profiling by array of flu-infected lungs of DBA/2J and C57BL/6J mice 1 to 4 days post infection |
2.2 | | Oasl2 | 'SARS coronavirus MA15' vs 'none' at '7 day' | infect, time | SM014 - SARS MA15 wild type, and SARS nsp16 mutant virus infections of C57BL6 mice - A time course |
2.2 | | Oasl2 | '3 day' vs '1 day' in 'influenza A infected C57BL/6J' | disease, strain, time | Transcription profiling by array of flu-infected lungs of DBA/2J and C57BL/6J mice 1 to 4 days post infection |
2.2 | | Oasl2 | 'status epilepticus' vs 'none' in 'microglia; none' | cell type, compound, disease | RNA-seq profiling of three distinct cell populations in a murine model of epilepsia with and without drug treatment |
-2.2 | | Oasl2 | 'Myd88 -/-' vs 'wild type genotype' in 'raised in germ-free environment; jejunum' | environmental history, genotype, organism part | Transcriptional profiling of intestinal tissue samples from germ-free and conventionally raised mice which are either wild-type or Myd88-/- |
2.2 | | Oasl2 | 'CpG ODN' vs 'PBS' at '24 hour' | compound, time | Transcription profiling by array of mouse vaginal samples following adjuvant treatment |
-2.2 | | Oasl2 | 'induced extraembryonic endoderm stem cell; grown in XEN cell medium' vs 'mouse embryonic fibroblast; control' | cell type, growth condition | OSKM induce extraembryonic endoderm stem (iXEN) cells in parallel to iPS cells |
2.2 | | Oasl2 | '14 month; QH2; liver' vs '14 month; control; liver' | age, compound, organism part | Coenzyme Q10-dependent gene expression in SAMP1 mice tissues |
-2.1 | | Oasl2 | 'Kit ligand' vs 'none' in 'wild type' | compound, genotype | Transcription profiling of bone marrow–derived mast cells from WASP-deficient mice after stimulation with kit ligand |
2.1 | | Oasl2 | 'Staphylococcus aureus Sanger476; 12 hour' vs 'none; 0 hour' in 'C57BL/6J' | infect, strain, time | Gene Expression-Based Classifiers Identify Staphylococcus aureus Infection in Mice and Humans |
-2.1 | | Oasl2 | 'ABIN1[D485N] knock-in' vs 'wild type genotype' in 'classical monocyte' | cell type, genotype | RNA-seq of inflammatory monocytes, patrolling monocytes and neutrophils in wild type and ABIN1[D485N] mice |
-2.1 | | Oasl2 | 'Kit ligand' vs 'none' in 'wasp knockout' | compound, genotype | Transcription profiling of bone marrow–derived mast cells from WASP-deficient mice after stimulation with kit ligand |
2.1 | | Oasl2 | 'lipopolysaccharide; 100 nanogram per milliliter and interferon gamma 20 nanogram per milliliter' vs 'none' | stimulus | Transcriptional profiling in macrophages in stimulated and unstimulated conditions. |
2.1 | | Oasl2 | 'Staphylococcus aureus Sanger476; 6 hour' vs 'none; 0 hour' in 'C57BL/6J' | infect, strain, time | Gene Expression-Based Classifiers Identify Staphylococcus aureus Infection in Mice and Humans |
2.1 | | Oasl2 | 'Staphylococcus aureus Sanger476; 6 hour' vs 'none; 0 hour' in 'A/J' | infect, strain, time | Gene Expression-Based Classifiers Identify Staphylococcus aureus Infection in Mice and Humans |
-2.1 | | Oasl2 | 'nutlin-3a; polarized with interleukin 4 and interleukin 13.' vs 'untreated' | compound, treatment | Expression data from polarized macrophages: effect of p53 |
2.1 | | Oasl2 | 'alphaGalCer' vs 'PBS/Tween 0.5%' at '24 hour' | compound, time | Transcription profiling by array of mouse vaginal samples following adjuvant treatment |
2.1 | | Oasl2 | 'SARS coronavirus MA15; 4 day' vs 'mock' in '129S1/SvImJ' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
-2.1 | | Oasl2 | '5,9-endoperoxy-cholest-7-en-3β,6α-diol' vs 'vehicle (cyclodextrin)' | compound, time | Array results for differential gene expression in 661W, a mouse cone photoreceptor-derived cell line, comparing cells incubated with vehicle controls vs. those treated with either of two 7-dehdyrocholesterol-derived oxysterols or cholesterol |
2.1 | | Oasl2 | 'sham-preconditioning followed by intra-amygdala kainic acid' vs 'sham-preconditioning followed by intra-amygdala vehicle' | clinical treatment | Transcription profiling by array of mice with epileptic tolerance |
2.1 | | Oasl2 | 'Chlamydia pneumoniae' vs 'mock' in 'MyD88 knockout' | genotype, infect | Transcription profiling of lungs from wild type and MyD88 knockout mice infected with Chlamydia pneumoniae to explore the influence of MyD88 on induction of immune responses. |
2.1 | | Oasl2 | 'unilateral ureteral obstruction' vs 'sham' in 'TIMP3 -/-' | genotype, treatment | TIMP2 and TIMP3 have divergent roles in early renal tubulointerstitial injury |
-2.1 | | Oasl2 | 'Myd88 -/-' vs 'wild type genotype' in 'raised in conventional environment; jejunum' | environmental history, genotype, organism part | Transcriptional profiling of intestinal tissue samples from germ-free and conventionally raised mice which are either wild-type or Myd88-/- |
2.1 | | Oasl2 | 'Influenza A virus (A/Puerto Rico/8/1934(H1N1)); 4 day' vs 'mock' in 'NZO/HILtJ' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
2.1 | | Oasl2 | 'lipid nanoparticle alone' vs 'phosphate buffered saline' | stimulus | Microarray analysis of mouse whole genome using self-amplifying messenger (SAM) RNA delivered with different formulations compared to controls |
2.1 | | Oasl2 | 'lipopolysaccharide; 10 nanogram per milliliter and SGC-CBP30; 10 nanogram per milliliter' vs 'none' in 'primary cell line; wild type genotype' | cell line, compound, genotype | Bulk RNA-seq of wild type and MEF2A or MEF2C/D knockout mouse bone marrow macrophages under different stimulation conditions |
2.1 | | Oasl2 | 'adult definitive erythroid cell' vs 'primitive erythroid cell' in 'mix of orthochromatic and polychromatophilic erythroblast' | cell type, phenotype | Transcription profiling by array of differentiating primary primitive and definitive mouse red blood cells |
2.1 | | Oasl2 | 'transgenic C3(1)-SV40Tag; 20 week' vs 'wild type; 8 week' | age, genotype | Prevention of mammary tumor progression by silencing HoxA1 via intraductal injection of nanoparticle-formulated siRNA |
2.1 | | Oasl2 | 'adult definitive erythroid cell' vs 'primitive erythroid cell' in 'reticulocyte' | cell type, phenotype | Transcription profiling by array of differentiating primary primitive and definitive mouse red blood cells |
-2.1 | | Oasl2 | 'IFNAR1 -/-' vs 'wild type genotype' in 'none' at '5 day' | genotype, infect, time | Transcriptomic analysis of host response to mouse-adapted SARS virus in wild type, STAT1 -/-, and IFNAR1 -/- mouse genetic backgrounds |
2 | | Oasl2 | 'adenoviral vector expressing human ACE2' vs 'empty adenoviral vector' | genotype | RNA-seq of SARS-CoV-2 infected lungs from mice sensitized for SARS-CoV-2 infection by Ad5-hACE2 transduction compared to non-sensitized mice |
2 | | Oasl2 | 'Mettl6 knockout clone D1' vs 'wild type genotype' | genotype | METTL6 is a tRNA m3C methyltransferase that regulates translation and tumor cell proliferation |
-2 | | Oasl2 | 'Mef2d deletion' vs 'wild type' | phenotype | Whole transcriptome sequencing of mouse regulatory T cells with and without Mef2d, Mef2c, HDAC1, HDAC2 or Dyrk1 deletion |
2 | | Oasl2 | '8.5 millimolar; methoxyacetic acid' vs 'none' at '24 hour' | compound, time | Transcription profiling by array of mouse embryonic stem cells after treatment with 5-fluourouracil, methoxyacetic acid, monobutl phthalate, Penicillin G, retinoic acid or valproic acid |
-2 | | Oasl2 | 'ABIN1[D485N] knock-in' vs 'wild type genotype' in 'neutrophil' | cell type, genotype | RNA-seq of inflammatory monocytes, patrolling monocytes and neutrophils in wild type and ABIN1[D485N] mice |
2 | | Oasl2 | 'curdlan' vs 'none' in 'wild type' | compound, genotype | Dendritic cell-derived IL-2 promotes apoptosis of terminally mature cells via a novel autocrine signaling pathway |
-2 | | Oasl2 | 'Er1F/-' vs 'wild type genotype' | genotype | RNA-Seq profiling of ERCC1-XPF DNA repair defect (Er1F/-) versus wild type (Er1F/+) macrophages |
-2 | | Oasl2 | 'co-cultured with hematopoietic stem cell for 9 days' vs 'non co-cultured for 9 days' in 'stromal cell; expressing AKT1' | cell type, growth condition, phenotype | Transcription profiling by high throughput sequencing of murine bone marrow endothelial cells and bone marrow stroma, in vitro and in vivo, with and without hematopoietic stem cells co-culture |
2 | | Oasl2 | 'trinitrobenzene sulfonic acid' vs 'none' in 'Fn14 knockout' | compound, genotype | Chronic TNBS Colitis in the FN14 KO Mouse |
2 | | Oasl2 | 'granulocyte' vs 'hemopoietic stem cell' | cell type | Gene expression data from mouse hemopoietic stem cells (LSKs), promyelocytes, myelocytes and granulocytes. |
2 | | Oasl2 | '15 day' vs '3 day' | time | Transcription profiling time series of mouse embryonic chondrocyte differentiation |
2 | | Oasl2 | '4 day' vs '1 day' in 'influenza A infected C57BL/6J' | disease, strain, time | Transcription profiling by array of flu-infected lungs of DBA/2J and C57BL/6J mice 1 to 4 days post infection |
2 | | Oasl2 | 'Staphylococcus aureus MW2; 2 hour' vs 'none; 0 hour' in 'A/J' | infect, strain, time | Gene Expression-Based Classifiers Identify Staphylococcus aureus Infection in Mice and Humans |
-2 | | Oasl2 | 'Ink4a/Arf-/-; EGFRvIII' vs 'wild type genotype' in 'co-culture' | genotype, growth condition | RNA-seq of wild-type and transformed Ink4a/Arf-/-; EGFRvIII neural stem cells in separate or co-culture conditions |
2 | | Oasl2 | 'Gata6 knockout' vs 'wild type' | phenotype | Global gene expression in the adult Gata6 null mouse pancreas |
-2 | | Oasl2 | 'Zbtb10 knockdown' vs 'control' at '6 hour' | genotype, time | RNA-seq of Zbtb10 Knockdown and Control cDC1 dendritic cells (Cd8+) |
-2 | | Oasl2 | 'Cdx2 knockdown' vs 'scramble shRNA' in 'induced hepatocyte' | cell type, genotype | Dissecting engineered cell types and enhancing cell fate conversion via CellNet |
1.9 | | Oasl2 | 'Mettl6 knockout clone G6' vs 'wild type genotype' | genotype | METTL6 is a tRNA m3C methyltransferase that regulates translation and tumor cell proliferation |
1.9 | | Oasl2 | 'R6/2 transgenic' vs 'wild type' in '12 week; brain cortex' | age, genotype, organism part | Transcription profiling by high throughput sequencing in wild type and R6/2 mutant mouse cortex and striatum at 8 and 12 weeks. |
1.9 | | Oasl2 | 'Mycobacterium tuberculosis H37Rv' vs 'none' in 'wild type' | compound, genotype, infect | 4-week mouse comparative study on effect of neutralizing IL-17A, IL-17F and TNFa antibodies |
1.9 | | Oasl2 | 'high fat diet; 30 degree celsius' vs 'chow; 23 degree celsius' in 'brown adipose tissue' | diet, organism part, temperature | RNA-seq of brown and white mouse adipose tissue at thermoneutrality and high-fat diet |
1.9 | | Oasl2 | 'Staphylococcus aureus Sanger476; 4 hour' vs 'none; 0 hour' in 'A/J' | infect, strain, time | Gene Expression-Based Classifiers Identify Staphylococcus aureus Infection in Mice and Humans |
1.9 | | Oasl2 | 'Plasmodium berghei' vs 'none' in 'none' | compound, infect | Transcription profiling by array of mouse blood infected with Plasmodium berghei after treatment with activated charcoal |
1.9 | | Oasl2 | '5 nanogram per milliliter; TGFbeta1' vs 'none' at '24 hour' | compound, time | Transcription profiling by array of mouse hepatocytes following treatment with growth factor beta 1 in a time series |
1.9 | | Oasl2 | 'TIMP1 knockout; SARS MA15; 7 day' vs 'TIMP1 knockout; mock' | genotype, infect, time | SARS infection of C57BL6, TIMP1 and Serpine1 knock-out mice |
1.9 | | Oasl2 | 'Escherichia coli O18:K1:H7; 6 hour' vs 'none; 0 hour' in 'C57BL/6J' | infect, strain, time | Gene Expression-Based Classifiers Identify Staphylococcus aureus Infection in Mice and Humans |
1.9 | | Oasl2 | 'H9; undifferentiated 3factor-reprogrammed induced pluripotent stem cell' vs 'R1; undifferentiated embryonic stem cell' at '0 day' | cell line, growth condition, time | Natural cardiogenesis-based template predicts cardiogenic potential of induced pluripotent stem cell lines |
1.9 | | Oasl2 | 'scrapie ME7 inoculated' at '150 day' vs 'none' at '0 day' | infect, time | Transcription profiling by array of brains from mice infected with scrapie ME7 |
-1.9 | | Oasl2 | 'promyelocyte' vs 'hemopoietic stem cell' | cell type | Gene expression data from mouse hemopoietic stem cells (LSKs), promyelocytes, myelocytes and granulocytes. |
1.9 | | Oasl2 | '14M1.4; Leishmania donovani infected' at '12 hour' vs '14M1.4; normal' at '12 hour' | cell line, infect, time | Transcription profiling of 3 mouse cell lines infected with Leishmania |
1.9 | | Oasl2 | 'transgenic hepatic growth hormone and hepatocyte-specific deletion of JAK2' vs 'wild type genotype' in '40 week' | age, genotype | Hepatic Deletion of Janus Kinase 2 Counteracts Inflammation, Oxidative Stress and Liver Cancer Formation in Growth Hormone Transgenic Mice |
1.9 | | Oasl2 | 'SARS coronavirus MA15 nsp16 -/-' vs 'none' at '4 day' | infect, time | SM014 - SARS MA15 wild type, and SARS nsp16 mutant virus infections of C57BL6 mice - A time course |
-1.9 | | Oasl2 | 'Nutlin-3a; 150 milligram per kilogram per day' vs 'none' in 'p53 heterozygous mutant' | compound, phenotype | RNA-seq of mouse colon to investigate how suppression of HSF1 activity by wildtype p53 creates a driving force for p53 loss-of-heterozygosity |
1.9 | | Oasl2 | '3 day' vs '1 day' in 'influenza A infected DBA/2J' | disease, strain, time | Transcription profiling by array of flu-infected lungs of DBA/2J and C57BL/6J mice 1 to 4 days post infection |
1.9 | | Oasl2 | '2 day' vs '1 day' in 'influenza A infected DBA/2J' | disease, strain, time | Transcription profiling by array of flu-infected lungs of DBA/2J and C57BL/6J mice 1 to 4 days post infection |
1.9 | | Oasl2 | 'Helicobacter hepaticus' vs 'none' in 'wild type phenotype' | infect, phenotype | Whole transcriptome profiling of the steady state and Hh-treated (8 hrs) Alpk1+/- (heterozygous) and Alpk1-/- (knockout) BMDMs using RNA-Sequencing approach |
-1.9 | | Oasl2 | 'dextran sodium sulphate induced colitis' at '7 day' vs 'normal' at '0 day' | disease, time | Transcription profiling by array of Mus musculus colonic mucosa after treatment with dextran sodium sulphate (DSS) for 2 or 7 days which induces experimental colitis |
-1.9 | | Oasl2 | 'IFNAR1 -/-' vs 'wild type genotype' in 'SARS coronavirus MA15' at '9 day' | genotype, infect, time | Transcriptomic analysis of host response to mouse-adapted SARS virus in wild type, STAT1 -/-, and IFNAR1 -/- mouse genetic backgrounds |
1.8 | | Oasl2 | 'nmf205, Gcn2 double mutant' vs 'wild type' | genotype | Transcription profiling by high throughput sequencing in cerebellum of mouse Gcn2 -/-, nmf205-/- and nmf205-/-;Gcn2-/- |
-1.8 | | Oasl2 | 'induced neuronal cell' vs 'pluripotent embryonic stem cell' | phenotype | Transcription profiling by high throughput sequencing of retinoic acid-differentiated neuronal cells compared to nondifferentiated pluripotent embryonic stem cells |
-1.8 | | Oasl2 | 'Abcc8-/-' vs 'wild type genotype' in 'normal; female' | diet, genotype, sex | Effects of increased intracellular calcium and overnutrition on pancreatic beta cell transcriptome |
1.8 | | Oasl2 | 'lung carcinoma' vs 'normal' in 'Epcam+CD11b-CD11c- epithelial cell' | cell type, disease | Transcriptome analysis of isolated stormal cells and tumor epithelial cells in mouse lung cancer by RNA-Seq |
1.8 | | Oasl2 | 'Plasmodium berghei ANKA; 4th infection after 3 rounds of infection and cure' vs 'none; uninfected' | block, clinical history, infect | Transcription profiling by array of brain from mice repeatedly infected with Plasmodium berghei to study infection-induced resistance to experimental cerebral malaria |
1.8 | | Oasl2 | '12 day' vs '3 day' | time | Transcription profiling time series of mouse embryonic chondrocyte differentiation |
1.8 | | Oasl2 | 'infarct and border region of left ventricle 5 days post-myocardial infarction; C57BL/6J' vs 'left ventricle at baseline (no myocardial infarction) in the same region as the infarct in post-myocardial infarction hearts; C57BL/6J' | clinical information, strain | Expression data from C57BL/6J and MRL/MpJ hearts following acute myocardial infarction |
-1.8 | | Oasl2 | 'Gabpa miRNA' vs 'control miRNA' in 'wild type genotype; re-fed' | RNA interference, diet, genotype | Gene expression profiling of liver from C57BLKS/J and db/db 8 mice with an AAV harboring a control or GAbpa-specific miRNA under the LP1 promoter |
1.8 | | Oasl2 | 'CXCR3 knockout; SARS MA15; 2 day' vs 'CXCR3 knockout; mock' | genotype, infect, time | Infection of wild type and CXCR3 knockout C57BL6/J mice with SARS MA15 |
1.8 | | Oasl2 | 'unilateral ureteral obstruction' vs 'sham' in 'TIMP2 -/-' | genotype, treatment | TIMP2 and TIMP3 have divergent roles in early renal tubulointerstitial injury |
-1.8 | | Oasl2 | 'Lin- CD44+ CD25- c-Kit+ thymocyte progenitor cell; embryonic day 14.5' vs 'Lin- CD44+ CD25- c-Kit+ thymocyte progenitor cell; adult' | cell type, developmental stage | Transcription profiling of mouse adult and fetal T cell progenitors |
1.8 | | Oasl2 | 'unilateral ureteral obstruction' vs 'sham' in 'wild type' | genotype, treatment | TIMP2 and TIMP3 have divergent roles in early renal tubulointerstitial injury |
1.8 | | Oasl2 | 'Escherichia coli O18:K1:H7; 12 hour' vs 'none; 0 hour' in 'C57BL/6J' | infect, strain, time | Gene Expression-Based Classifiers Identify Staphylococcus aureus Infection in Mice and Humans |
1.8 | | Oasl2 | 'cancer' vs 'normal' in 'lymph node medullary sinus macrophage' | cell type, disease | RNA Sequencing of CD169+ lymph node macrophages isolated from naïve or tumor-bearing mice |
1.8 | | Oasl2 | 'control mice [Gp130f/f]; cecal ligation and puncture' vs 'control mice [Gp130f/f]; control' | genotype, treatment | Hepatic acute phase proteins control innate immune responses during infection by promoting myeloid derived suppressor cell function |
1.8 | | Oasl2 | 'vimentin deficient' vs 'wild type' | genotype | Expression data from bone marrow-derived macrophages |
1.8 | | Oasl2 | 'Staphylococcus aureus cutaneous infection' vs 'none' in 'IL-1R knockout' | disease, genotype | Neutrophil-derived IL-1β is sufficient for abscess formation in immunity against Staphylococcus aureus in mice |
1.7 | | Oasl2 | 'Drosha -/-' vs 'wild type genotype' | genotype | RNA-seq of mouse ES cells with conditional Drosha knockout against wild type controls to identify pri-miRNAs |
-1.7 | | Oasl2 | 'Abcc8-/-' vs 'wild type genotype' in 'normal; male' | diet, genotype, sex | Effects of increased intracellular calcium and overnutrition on pancreatic beta cell transcriptome |
-1.7 | | Oasl2 | 'overexpression of alpha- and beta- Hb chains' vs 'control vector' | genotype | Unexpected expression of alpha- and beta-globin in mesencephalic dopaminergic neurons and glial cells |
1.7 | | Oasl2 | '14 days P. chabaudi infected' vs 'uninfected' in 'gonadectomized male' | clinical information, disease, sex, time | Transcription profiling by array of mice infected with Plasmodium chabaudi after gonadectomization to investigate involvement of gonadal steroids |
-1.7 | | Oasl2 | 'MHC II overexpression'vs 'empty retroviral vector' | phenotype | Effect of MHC II expression in pro-B cells: F6 leukaemic cell line |
1.7 | | Oasl2 | 'wild type; SARS MA15; 7 day' vs 'wild type; mock' | genotype, infect, time | Infection of wild type and CXCR3 knockout C57BL6/J mice with SARS MA15 |
1.7 | | Oasl2 | 'CCl4 and diethylnitrosamine' vs 'none' in 'wild type genotype' | genotype, treatment | Gene expression accompanying the promotion of hepatocellular carcinoma by intestinal microbiota and Tlr4 in mice. |
1.7 | | Oasl2 | 'lung carcinoma' vs 'normal' in 'lung cell' | cell type, disease | Transcriptome analysis of isolated stormal cells and tumor epithelial cells in mouse lung cancer by RNA-Seq |
1.7 | | Oasl2 | 'postnatal >1 year; hindlimb' vs 'embryonic day 17.5; whole forelimb and hindlimb' | age, organism part | Expression data from skeletal muscle satellite cells at different development stages |
1.7 | | Oasl2 | '3 days P. chabaudi infected' vs 'uninfected' in 'gonadectomized male' | clinical information, disease, sex, time | Transcription profiling by array of mice infected with Plasmodium chabaudi after gonadectomization to investigate involvement of gonadal steroids |
1.7 | | Oasl2 | 'Influenza A virus (A/Puerto Rico/8/1934(H1N1)); 2 day' vs 'mock' in 'C57BL/6J' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
1.7 | | Oasl2 | 'PGC-1 beta knock in' vs 'wild type' | genotype | Transcription profiling by array of skeletal muscle from PGC-1 beta transgenic mice |
1.7 | | Oasl2 | 'SARS coronavirus MA15' vs 'none' in 'Tnfrsf1a/1b -/-' at '7 day' | genotype, infect, time | SM015 - Infection with SARS MA15 of C57BL/6J mice and Tnfrsf1a/1b knockouts |
-1.7 | | Oasl2 | 'MYC inhibitor (10058F4); polarized with interleukin 4 and interleukin 13.' vs 'untreated' | compound, treatment | Expression data from polarized macrophages: effect of p53 |
1.7 | | Oasl2 | 'Trypanosoma brucei STIB247' vs 'uninfected' | infect | Transcription profiling by array of spleens from mice infected with different Trypanosoma brucei strains |
1.7 | | Oasl2 | 'PLAT knockout; SARS MA15; 7 day' vs 'PLAT knockout; mock' | genotype, infect, time | SARS infection of C57BL6, and PLAT knock-out mice |
1.7 | | Oasl2 | 'uterine-specific Tsc2-null' vs 'wild type' in 'oopherectomized' | genotype, treatment | Transcription profiling by high throughput sequencing of uterine-specific Tsc2-null mice |
1.7 | | Oasl2 | 'acute DSS-induced colitis; 1x DSS, no recovery' vs 'none; none' | clinical treatment, disease | Transcription profiling by array of colon tissues isolated from mice with acute and chronic dextran sodium sulphate (DSS)-induced colitis |
1.7 | | Oasl2 | 'Staphylococcus aureus USA100; 2 hour' vs 'none; 0 hour' in 'A/J' | infect, strain, time | Gene Expression-Based Classifiers Identify Staphylococcus aureus Infection in Mice and Humans |
-1.7 | | Oasl2 | 'V6.5; embryonic stem cell’ vs 'wild type; endothelial' | cell line, cell type, genotype | CD47 Inhibits Self-renewal and Reprogramming by Regulating c-Myc and Other Stem Cell Transcription Factors |
1.7 | | Oasl2 | 'Escherichia coli O18:K1:H7; 24 hour' vs 'none; 0 hour' in 'CD1' | infect, strain, time | Gene Expression-Based Classifiers Identify Staphylococcus aureus Infection in Mice and Humans |
1.7 | | Oasl2 | 'Smad4f/f x CCSPicrePtenf/f' vs 'wild type' at '12 month' | age, genotype | ErbB2 Pathway Activation upon Smad4 Loss Promotes Lung Tumor Growth and Metastasis [expression] |
1.7 | | Oasl2 | 'Aeromonas caviae' vs 'none' | infect | Transcription profiling by array of small intestinal extract of mice 24 hours after Aeromonas caviae infection |
-1.7 | | Oasl2 | 'rosiglitazone; 100 nanomolar' vs 'none' in 'wild type genotype' | compound, genotype | Transcriptional response to Rosiglitazone in adipocyte progenitors isolated from WT and Cited4-KO scWAT |
1.7 | | Oasl2 | 'bER knockout' vs 'wild type' in 'human chorionic gonadotropin; 5 International Unit' | compound, genotype | Laser Capture Microdissection isolation of preovulatory granulosa cells from WT and bERKO ovaries |
-1.7 | | Oasl2 | 'Cbir-flagellin' vs 'none' in 'B6-interleukin 10-/-' | stimulus, strain | Transcription profiling of bone marrow-derived macrophages from colitis-resistant and colitis-susceptible interleukin-10-deficient strains stimulated with Cbir-flagellin |
1.6 | | Oasl2 | 'ATF5 knockdown' vs 'wild type' in 'DMSO' | compound, genotype | Microarray to find ATF5 dependent genes in response to proteasome inhibition |
1.6 | | Oasl2 | 'T-cell depleted bone marrow transplant' vs 'none' in 'normal' | disease, stimulus | RNA-Seq of lymph node fibroblastic reticular cells isolated from bone marrow transplant recipient mice with or without acute Graft-versus-host disease on day 7 or untransplanted control mice |
1.6 | | Oasl2 | 'CD2AP-/-' vs 'wild type genotype' in 'renal glomerular endothelial cell' | cell type, genotype | Transcription profiling by array of three major cell types of the glomerulus (podocytes, mesangial cells and endothelial cells) from CD2AP-/- mutant mice and normal controls |
1.6 | | Oasl2 | 'CpG ODN' vs 'PBS' at '4 hour' | compound, time | Transcription profiling by array of mouse vaginal samples following adjuvant treatment |
-1.6 | | Oasl2 | 'fasted' vs 're-fed' in 'wild type genotype; control miRNA' | RNA interference, diet, genotype | Gene expression profiling of liver from C57BLKS/J and db/db 8 mice with an AAV harboring a control or GAbpa-specific miRNA under the LP1 promoter |
-1.6 | | Oasl2 | 'polarized with interleukin 4 and interleukin 13.' vs 'untreated' | compound, treatment | Expression data from polarized macrophages: effect of p53 |
1.6 | | Oasl2 | 'chronic DSS-induced colitis; 2x DSS, recovery' vs 'none; none' | clinical treatment, disease | Transcription profiling by array of colon tissues isolated from mice with acute and chronic dextran sodium sulphate (DSS)-induced colitis |
-1.6 | | Oasl2 | 'STAT1 -/-' vs 'wild type genotype' in 'SARS coronavirus MA15' at '9 day' | genotype, infect, time | Transcriptomic analysis of host response to mouse-adapted SARS virus in wild type, STAT1 -/-, and IFNAR1 -/- mouse genetic backgrounds |
1.6 | | Oasl2 | 'NeuroD1 conditional knockout' vs 'control' in 'retina' at 'Zeitgeber time 6' | genotype, organism part, sampling time point | Gene expression profile of retina and pineal gland of NeuroD1 conditional knockout mice |
1.6 | | Oasl2 | 'upf3 knockout' vs 'wild type' in 'testis' | cell type, genotype | UPF2 establishes testis-specific transcriptome enriched in transcripts with shorter 3’UTRs |
-1.6 | | Oasl2 | 'conditional UPF2 knockout; 36 hour after partial hepatechtomy' vs 'control; 36 hour after partial hepatechtomy' | genotype, sampling time | Transcription profiling of livers of adult UPF2 null mice in response to partial hepatechtomy |
1.6 | | Oasl2 | 'Klf1-/-' vs 'wild type' | genotype | Novel roles for Klf1 in regulating the erythroid transcriptome revealed by mRNA-seq |
1.6 | | Oasl2 | 'scrapie ME7 inoculated' at '90 day' vs 'none' at '0 day' | infect, time | Transcription profiling by array of brains from mice infected with scrapie ME7 |
1.6 | | Oasl2 | 'heart-specific Mdm2 knockout; 14 day' vs 'heart-specific Mdm2 knockout; 7 day' | phenotype, time | Transcription profiling of heart tissue from mice with heart-specific knockout of p53 and Mdm2 |
-1.6 | | Oasl2 | 'Ifnar1 knockout' vs 'wild type genotype' in 'specific pathogen free C57BL/6' | genotype, strain | RNA sequencing of primary isolated unstimulated murine splenic cDC from specific pathogen free (SPF), Germ Free (GF) and Interferon alpha/beta receptor 1 (Ifnar) knock out mice. |
1.6 | | Oasl2 | 'extracellular vesicle; MET cell culture medium' vs 'none' | sampling site, stimulus | Cellular and extracellular vesicle RNA sequence for E-cadherin-RFP EMT reporter system expressing mouse breast cancer cell line Py2T during EMT/MET |
1.6 | | Oasl2 | '4 day' vs '1 day' in 'influenza A infected DBA/2J' | disease, strain, time | Transcription profiling by array of flu-infected lungs of DBA/2J and C57BL/6J mice 1 to 4 days post infection |
-1.6 | | Oasl2 | 'MEF2C/D knockout' vs 'wild type genotype' in 'primary cell line; none' | cell line, compound, genotype | Bulk RNA-seq of wild type and MEF2A or MEF2C/D knockout mouse bone marrow macrophages under different stimulation conditions |
1.5 | | Oasl2 | 'epithelium-specific Apc; Bcl9; Bcl9l knockout' vs 'wild type' | phenotype | RNAseq of murine small intestinal tissue following epithelium-specific deletion of Bcl9/9l +/- Apc +/- mutant B-catenin |
1.5 | | Oasl2 | 'RBM20 antisense oligonucleotide' vs 'none' in 'Titin-N2B knockout' | RNA interference, genotype | Heart RNA-seq of therapeutic RBM20 antisense oligonucleotide (ASO) treatment in a mouse model of heart failure with preserved ejection fraction (HFpEF) |
1.5 | | Oasl2 | 'Mycobacterium tuberculosis H37Rv' vs 'none' | infect | The global transcriptome of whole lungs extracted from M. tuberculosis infected C57BL6 mice |
1.5 | | Oasl2 | 'SOD1-G93A transgenic' vs 'wild type' at 'day 65' in 'B6/SJL' | genotype, sampling time point, strain | Transcription profiling by high throughput sequencing of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model |
-1.5 | | Oasl2 | 'Porphyromonas gingivalis; hyperlipidemia' vs 'normal' | infect, phenotype | hyperlipidemia impaired innate response |
-1.5 | | Oasl2 | 'TLR4 mutant' vs 'wild type genotype' in 'CCl4 and diethylnitrosamine' | genotype, treatment | Gene expression accompanying the promotion of hepatocellular carcinoma by intestinal microbiota and Tlr4 in mice. |
1.5 | | Oasl2 | 'ATF3 -/-' vs 'wild type' in '10 nanogram per milliliter; lipopolysaccharide' at '2 hour' | compound, genotype, time | Transcription profiling by array of mouse bone marrow macrophages mutant for ATF3 after treatment with lipopolysaccharide |
1.5 | | Oasl2 | 'triolein; PPARalpha knockout' vs 'triolein; wild type' | compound, genotype | Gene expression profile of PPARalpha knockout and wild type mice after a single oral dose of different synthetic triglycerides |
1.5 | | Oasl2 | 'chronic cystitis' vs 'none' in 'C57/Bl6' | disease, strain | Chronic cystitis microarray comparing C3H/HeN and C57BL/6 bladder gene expression |
1.5 | | Oasl2 | '0.8 millimolar; valproic acid' vs 'none' at '24 hour' | compound, time | Transcription profiling by array of mouse embryonic stem cells after treatment with 5-fluourouracil, methoxyacetic acid, monobutl phthalate, Penicillin G, retinoic acid or valproic acid |
1.5 | | Oasl2 | 'CDK4/6 inhibitor PD 0332991' vs 'vehicle' | compound | Gene expression profile of mouse breast cancer V720 cells treated with vehicle or PD 0332991 |
1.5 | | Oasl2 | 'BL6; RML infected' at '16 week' vs 'BL6; uninfected' at '16 week' | strain, time, treatment | Transcription profiling of mouse brain infected with prions in eight mouse-prion strain combinations in a systems approach to the study of prion disease |
1.5 | | Oasl2 | 'ko cyld-/-' vs 'wild type' | genotype | Transcription profiling by array of mouse liver with Cyld inactivation |
1.5 | | Oasl2 | 'MOG35-55' vs 'none' at '40 day' | compound, time | Transcriptomic profiling in the animal model of multiple sclerosis |
-1.5 | | Oasl2 | 'diet restriction' vs 'control' | diet | Liver mRNA microarray study for mice treated with various diets |
1.5 | | Oasl2 | 'interferon gamma' vs 'none' | compound | Type I and II Interferon-Stimulated Genes in Murine Primary Bone Marrow Macrophages |
1.5 | | Oasl2 | 'chronic DSS-induced colitis; 1x DSS, recovery' vs 'none; none' | clinical treatment, disease | Transcription profiling by array of colon tissues isolated from mice with acute and chronic dextran sodium sulphate (DSS)-induced colitis |
1.5 | | Oasl2 | 'SARS coronavirus MA15 nsp16 -/-' vs 'none' at '7 day' | infect, time | SM014 - SARS MA15 wild type, and SARS nsp16 mutant virus infections of C57BL6 mice - A time course |
1.5 | | Oasl2 | 'chronic DSS-induced colitis; 3x DSS, recovery' vs 'none; none' | clinical treatment, disease | Transcription profiling by array of colon tissues isolated from mice with acute and chronic dextran sodium sulphate (DSS)-induced colitis |
-1.5 | | Oasl2 | 'missense mutation (G9492A) in Mucin 2 (Muc2)' vs 'wild type genotype' | genotype | Transcription profiling of mouse intestine in ENU mutagenesis mouse strains with missense mutations in Muc2 mucin and ER stress |
-1.5 | | Oasl2 | 'conditional UPF2 knockout; 36 hour after partial hepatechtomy' vs 'conditional UPF2 knockout; before partial hepatechtomy' | genotype, sampling time | Transcription profiling of livers of adult UPF2 null mice in response to partial hepatechtomy |
-1.5 | | Oasl2 | 'Myd88 -/-' vs 'wild type genotype' in 'raised in conventional environment; ileum' | environmental history, genotype, organism part | Transcriptional profiling of intestinal tissue samples from germ-free and conventionally raised mice which are either wild-type or Myd88-/- |
1.5 | | Oasl2 | 'Chikungunya virus; late stage encephalitis' vs 'early stage encephalitis' | infect, time | Transcriptomic profiling of the brains of WNV and CHIKV infection-induced encephalitis in young mice after 2, 3 or 5 days post infection |
1.5 | | Oasl2 | 'curdlan' vs 'none' in 'IL2 knockout' | compound, genotype | Dendritic cell-derived IL-2 promotes apoptosis of terminally mature cells via a novel autocrine signaling pathway |
1.5 | | Oasl2 | 'SARS coronavirus MA15' vs 'none' in 'wild type genotype' at '7 day' | genotype, infect, time | SM020 - Infection with SARS MA15 of C57BL/6J mice and KEPI (ppp1r14c) knockouts |
1.5 | | Oasl2 | 'adult definitive erythroid cell' vs 'primitive erythroid cell' in 'basophilic erythroblast' | cell type, phenotype | Transcription profiling by array of differentiating primary primitive and definitive mouse red blood cells |
1.5 | | Oasl2 | 'Influenza A virus (A/Puerto Rico/8/1934(H1N1)); 2 day' vs 'mock' in 'NZO/HILtJ' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
1.5 | | Oasl2 | 'transgenic hepatic growth hormone and hepatocyte-specific deletion of JAK2' vs 'wild type genotype' in '12 week' | age, genotype | Hepatic Deletion of Janus Kinase 2 Counteracts Inflammation, Oxidative Stress and Liver Cancer Formation in Growth Hormone Transgenic Mice |
1.5 | | Oasl2 | 'Pentachloronitrobenzene; 8187 part per million; rodent chow' vs 'none; ; rodent chow' | compound, treatment | Transcription profiling by array of Mus musculus liver tissue after exposure to various carcinogenic chemicals |
1.5 | | Oasl2 | "Evi1-GFP positive" vs "Evi1-GFP negative" | phenotype | Whole genome expression profiling of Evi1-GFP positive and negative murine hematopoietic stem cell sub-populations. |
-1.5 | | Oasl2 | 'dox-induced over-expression of oncogenes for 5 days' vs 'untreated control' | phenotype | Temporal Transcriptional Profiling in response to cMYC and KrasG12D Expression and Inactivation in In Vitro Cultured Primary Mammary Epithelial Cells of Adult Virgin Mice |
1.5 | | Oasl2 | 'lipopolysaccharide; 1 microgram per milliliter' vs 'none' in 'wild type' | compound, genotype | Inhibitor of NFκB ζ (IκBζ) is a transcriptional key regulator of monocyte chemoattractant protein-1 (MCP-1/CCL2) |
1.5 | | Oasl2 | 'Staphylococcus aureus USA300; 2 hour' vs 'none; 0 hour' in 'A/J' | infect, strain, time | Gene Expression-Based Classifiers Identify Staphylococcus aureus Infection in Mice and Humans |
1.5 | | Oasl2 | 'lipopolysaccharide; 1 microgram per milliliter' vs 'none' in 'Nfkbiz-/-' | compound, genotype | Inhibitor of NFκB ζ (IκBζ) is a transcriptional key regulator of monocyte chemoattractant protein-1 (MCP-1/CCL2) |
-1.5 | | Oasl2 | 'adipogenic' vs 'non-adipogenic' | phenotype | Transcription profiling by array of mouse sublines of Swiss 3T3 fibroblasts with varying potential for adipogenesis |
1.5 | | Oasl2 | 'transgenic hepatic growth hormone' vs 'wild type genotype' in '40 week' | age, genotype | Hepatic Deletion of Janus Kinase 2 Counteracts Inflammation, Oxidative Stress and Liver Cancer Formation in Growth Hormone Transgenic Mice |
1.5 | | Oasl2 | 'Col1a1-tetO-MLL/ENL' vs 'wild type' in 'precursor for granulocyte-macrophage progenitor cell' | cell type, genotype | Transcription profiling by high throughput sequencing of hematopoietic stem cells from a conditional-inducible mouse model of the MLL-ENL fusion oncogene |
-1.4 | | Oasl2 | 'Zbtb2 -/-' vs 'wild type genotype' in '2iLIF' at '0 day' | genotype, growth condition, time | RNA-seq for wild-type and Zbtb2 knock-out clones of mESCs in 2iLIF, EpiLC and SerumLIF conditions. |
-1.4 | | Oasl2 | 'butyrate' vs 'none' | compound | HDAC inhibition by TSA and Butyrate In Flt3L-elicited DC |
1.4 | | Oasl2 | '14 days P. chabaudi infected' vs 'uninfected' in 'gonadectomized female' | clinical information, disease, sex, time | Transcription profiling by array of mice infected with Plasmodium chabaudi after gonadectomization to investigate involvement of gonadal steroids |
1.4 | | Oasl2 | 'anti-CD3/anti-CD28' vs 'none' in 'FOXP3 overexpression' | genotype, stimulus | Transcription profiling by array of FOXP3 overexpression in resting and activated mouse CD4+ T cells |
-1.4 | | Oasl2 | 'Myd88 -/-' vs 'wild type genotype' in 'raised in conventional environment; duodenum' | environmental history, genotype, organism part | Transcriptional profiling of intestinal tissue samples from germ-free and conventionally raised mice which are either wild-type or Myd88-/- |
-1.4 | | Oasl2 | 'co-transplanted with NOD-scid IL2Rgamma null HSCs' vs 'co-transplanted with wild type HSCs' | growth condition | RNA-seq of mouse wildtype HSCs purified from recipient mice co-transplanted with wildtype or different types of lymphoid cell deficient HSCs |
-1.4 | | Oasl2 | 'Cbfb knockout' vs 'control of Cbfb knockout' | genotype | Transcription profiling by array of Mus musculus expressing Cbfb-MYH11 |
1.4 | | Oasl2 | 'transplanted secondary tumors' vs 'normal' in 'kidney' | clinical information, organism part | Premature termination of in vivo reprogramming leads to cancer development through altered epigenetic regulation [array] |
1.4 | | Oasl2 | '14 days P. chabaudi infected' vs 'uninfected' in 'intact female' | clinical information, disease, sex, time | Transcription profiling by array of mice infected with Plasmodium chabaudi after gonadectomization to investigate involvement of gonadal steroids |
-1.4 | | Oasl2 | 'IFNAR1 -/-' vs 'wild type genotype' in 'SARS coronavirus MA15' at '2 day' | genotype, infect, time | Transcriptomic analysis of host response to mouse-adapted SARS virus in wild type, STAT1 -/-, and IFNAR1 -/- mouse genetic backgrounds |
1.4 | | Oasl2 | '3 days P. chabaudi infected' vs 'uninfected' in 'intact; male' | clinical information, disease, sex, time | Transcription profiling by array of mice infected with Plasmodium chabaudi after gonadectomization to investigate involvement of gonadal steroids |
1.4 | | Oasl2 | 'NeuroD1 conditional knockout' vs 'control' in 'retina' at 'Zeitgeber time 20' | genotype, organism part, sampling time point | Gene expression profile of retina and pineal gland of NeuroD1 conditional knockout mice |
1.4 | | Oasl2 | 'Cnot3 knockout' vs 'wild type' | phenotype | RNA-seq of mouse islets from Ins1-cre driven Cnot3 KO and control islets |
1.4 | | Oasl2 | 'interferon gamma; 1 nanogram per milliliter' vs 'none' | stimulus | Analysis of transcriptomes in intestinal stem cells in response to Interferon gamma |
1.4 | | Oasl2 | 'Escherichia coli O18:K1:H7; 24 hour' vs 'none; 0 hour' in 'C57BL/6J' | infect, strain, time | Gene Expression-Based Classifiers Identify Staphylococcus aureus Infection in Mice and Humans |
1.4 | | Oasl2 | 'UV' vs 'sham' in 'AG825' at '6 hour' | irradiate, time | Transcription profiling by array of mouse dorsal skin exposed to UV radiation vs controls in mice treated with DMSO or selective tyrosine kinase inhibitor AG825 |
1.4 | | Oasl2 | '6 day' vs '0 day' | time | Transcription profiling by array of mouse colon tissues under dextran sodium sulphate induction for 2, 4 and 6 days against uninduced controls at day 0 |
-1.4 | | Oasl2 | 'neoplasm' vs 'normal tissue adjacent to neoplasm' | sampling site | Transcription profiling by array of Apc+/Delta716 mouse intestinal polyps vs normal intestinal mucosa |
-1.4 | | Oasl2 | 'heart-specific p53 knockout; 7 day' vs 'wild type phenotype' | phenotype, time | Transcription profiling of heart tissue from mice with heart-specific knockout of p53 and Mdm2 |
-1.4 | | Oasl2 | 'ductus arteriosis' vs 'aorta' | organism part | Gene Profiling in Mouse Fetal Ductus Arteriosus |
-1.4 | | Oasl2 | 'heart-specific Mdm2 knockout; 7 day' vs 'wild type phenotype' | phenotype, time | Transcription profiling of heart tissue from mice with heart-specific knockout of p53 and Mdm2 |
-1.3 | | Oasl2 | 'IRAK1BP1 KO' vs 'wild type' in 'TNFα' | genotype, treatment | Identification of TNFα-induced genes that are IRAK1BP1 dependent |
-1.3 | | Oasl2 | '4μ8C; 15 micromolar' vs 'none' in 'T-helper 2 cell' at '6 day' | cell type, compound, time | Effect of the IRE1a-XBP1 pathway inhibition during T helper 2 differentiation |
1.3 | | Oasl2 | 'collagen sandwich' at '2 day' vs 'freshly isolated' at '0 day' | growth condition, time | Transcription profiling of primary mouse hepatocytes under different culture conditions |
1.3 | | Oasl2 | 'ATF3 -/-' vs 'wild type' in 'none' at '0 hour' | compound, genotype, time | Transcription profiling by array of mouse bone marrow macrophages mutant for ATF3 after treatment with lipopolysaccharide |
1.3 | | Oasl2 | 'trans-tympanically injected with Hemophilus influenza' vs 'control' | treatment | Otitis Media Impact on Inner Ear |
-1.3 | | Oasl2 | 'doxycycline; no induction of Sp1 expression' vs 'none; wild type human Sp1 expression' | compound, genotype | Transcription profiling of mouse hematopoietic Baf-3 cells inducibly expressing transcription factor Sp1 |
1.3 | | Oasl2 | '27 week; R6/1 transgenic' vs '27 week; wild_type' | age, genotype | Transcription profiling of HD R6/1 transgenic mouse line brain hemispheres, time series |
1.3 | | Oasl2 | '70 days of tuberculosis' vs 'uninfected' | disease, time | Transcription profiling by array of lungs from mice infected with tuberculosis |
1.3 | | Oasl2 | 'B6I1; 301V infected' at '14 week' vs 'B6I1; uninfected' at '14 week' | strain, time, treatment | Transcription profiling of mouse brain infected with prions in eight mouse-prion strain combinations in a systems approach to the study of prion disease |
-1.3 | | Oasl2 | 'homozygous RYR1 mutant' vs 'RYR1 wild type' in 'embryonic day 14.5' | developmental stage, genotype | Microarrays of mouse embryonic limb skeletal muscle at days E14.5 and E18.5 lacking the RYR1 or Cav1.1 Ca2+ channels |
1.3 | | Oasl2 | 'Adjuvant System 03' vs 'PBS' in 'lymph node' at '6 hour' | organism part, stimulus, time | Expression data from draining lymph node and muscle of mice immunised with AS03 or PBS |
1.3 | | Oasl2 | '7 days P. chabaudi infected' vs 'uninfected' in 'intact female' | clinical information, disease, sex, time | Transcription profiling by array of mice infected with Plasmodium chabaudi after gonadectomization to investigate involvement of gonadal steroids |
-1.3 | | Oasl2 | 'caloric restriction' vs 'ad libitum' in 'wild type genotype' | diet, genotype | Microarray for duodenum epithelium of C57Bl6 PPARgVillinCRE and wild type mice submitted to 2 weeks 75% caloric restriction compared to ad libitum fed controls |
1.3 | | Oasl2 | 'confluent monolayer on collagen' at '1 day' vs 'freshly isolated' at '0 day' | growth condition, time | Transcription profiling of primary mouse hepatocytes under different culture conditions |
1.3 | | Oasl2 | 'Staphylococcus aureus Sanger476; 4 hour' vs 'none; 0 hour' in 'C57BL/6J' | infect, strain, time | Gene Expression-Based Classifiers Identify Staphylococcus aureus Infection in Mice and Humans |
1.3 | | Oasl2 | 'Albumin Cre+/-;Hnf4a fl/fl' vs 'wild type genotype' | genotype | Transcription profiling by array of liver-specific Hnf4alpha knock-out mice |
1.3 | | Oasl2 | 'Ptenf/f x CCSPiCre' vs 'wild type' at '7 month' | age, genotype | ErbB2 Pathway Activation upon Smad4 Loss Promotes Lung Tumor Growth and Metastasis [expression] |
1.3 | | Oasl2 | 'Crx knockout' vs 'control' at '20 zeitgeber' | genotype, time | Transcriptome in 129sv and Crx-/- pineal gland at ZT (Zeitgeber time) 6 and ZT20 |
-1.3 | | Oasl2 | 'db/db' vs 'wild type genotype' in 'control miRNA; re-fed' | RNA interference, diet, genotype | Gene expression profiling of liver from C57BLKS/J and db/db 8 mice with an AAV harboring a control or GAbpa-specific miRNA under the LP1 promoter |
-1.3 | | Oasl2 | 'Lin- CD44+ CD25+ thymocyte progenitor cell; embryonic day 14.5' vs 'Lin- CD44+ CD25+ thymocyte progenitor cell; adult' | cell type, developmental stage | Transcription profiling of mouse adult and fetal T cell progenitors |
1.3 | | Oasl2 | '5 day; Ad-VEGF-A164' vs '0 day; control' | time, treatment | Transcription profiling by array of stromal-based signatures for the classification of gastric cance |
1.3 | | Oasl2 | 'hepatocyte-specific Pten and Tgfbr2 knockout' vs 'wild type' | genotype | Hepatocyte-specific knockout of Pten and of Pten and Tgfbr2 in mice |
1.3 | | Oasl2 | 'fl-CBP/Foxp3cre' vs 'wild type' | genotype | Two Histone/Protein Acetyltransferases, CBP and p300, Are Indispensable for Foxp3+ T-regulatory Cell Development and Function |
1.3 | | Oasl2 | 'cardiotoxin; 10 micromolar' vs 'none' in 'wild type genotype' | compound, genotype | RNA-seq comparison of fibro-adipogenic progenitors (FAPs) from wild type, mdx and cardiotoxin-injured mice |
1.3 | | Oasl2 | 'hepatocyte-specific Pten knockout' vs 'wild type' | genotype | Hepatocyte-specific knockout of Pten and of Pten and Tgfbr2 in mice |
-1.3 | | Oasl2 | 'spontaneous lung tumor' vs 'normal' | disease state, disease | Transcription profiling by array of spontaneous lung tumors in mice to compare to human non-small cell lung cancer |
1.3 | | Oasl2 | 'azoxymethane and dextran sodium sulfate' vs 'control' in 'Myd88 knockout' | compound, genotype | Gene expression profiling of total colon in AOM/DSS-treated Myd88 knockout and wild type |
-1.3 | | Oasl2 | 'S6K1 knockout' vs 'wild type' in 'liver' | genotype, organism part | Transcription profiling of mouse long-lived S6K1 -/- strain females compared to wild types |
1.2 | | Oasl2 | 'artesunate and chloroquine (at same dosage); 30 milligram per kilogram; Plasmodium berghei ANKA; 10 day' vs 'none; none; 0 day' | compound, infect, sampling time point | RNA-seq analysis of anti-malarial drug chemotherapy of murine experimental Cerebral Malaria (ECM) |
1.2 | | Oasl2 | 'RBM20 antisense oligonucleotide' vs 'none' in 'wild type genotype' | RNA interference, genotype | Heart RNA-seq of therapeutic RBM20 antisense oligonucleotide (ASO) treatment in a mouse model of heart failure with preserved ejection fraction (HFpEF) |
1.2 | | Oasl2 | 'high fat diet' vs 'normal chow' in '28 week; ReverbαFlox2-6AdipoCre-' | age, diet, genotype | Tissue-autonomous regulation of adipose expansion by core clock protein REVERBα |
1.2 | | Oasl2 | '3110043O21Rik knockout; liver' vs 'wild type genotype; liver' | genotype, organism part, sampling site | RNAseq of coding RNA in the liver, spleen, kidney, abdominal muscle and gonadal adipose tissue of knock out mice and wild type controls. |
1.2 | | Oasl2 | 'anti-CD3/anti-CD28' vs 'none' in 'empty vector' | genotype, stimulus | Transcription profiling by array of FOXP3 overexpression in resting and activated mouse CD4+ T cells |
-1.2 | | Oasl2 | 'IRAK1BP1 KO' vs 'wild type' in 'none' | genotype, treatment | Identification of TNFα-induced genes that are IRAK1BP1 dependent |
1.2 | | Oasl2 | '6 day' vs '0 day' | age | Transcription profiling of mouse embyronic stem cell line CGR8 during the first 10 days of differentiation into embryoid bodies |
1.2 | | Oasl2 | 'epithelium-specific Apc knockout' vs 'wild type' | phenotype | RNAseq of murine small intestinal tissue following epithelium-specific deletion of Bcl9/9l +/- Apc +/- mutant B-catenin |
-1.2 | | Oasl2 | 'trichostatin A' vs 'none' | compound | HDAC inhibition by TSA and Butyrate In Flt3L-elicited DC |
1.2 | | Oasl2 | 'confluent monolayer on collagen' at '2 day' vs 'freshly isolated' at '0 day' | growth condition, time | Transcription profiling of primary mouse hepatocytes under different culture conditions |
1.2 | | Oasl2 | 'interleukin-3 and interleukin-33' vs 'interleukin-3' | growth condition | Stem cell factor programs the mast cell activation phenotype |
1.2 | | Oasl2 | '3 days P. chabaudi infected' vs 'uninfected' in 'gonadectomized female' | clinical information, disease, sex, time | Transcription profiling by array of mice infected with Plasmodium chabaudi after gonadectomization to investigate involvement of gonadal steroids |
-1.2 | | Oasl2 | 'Rel -/-; Nfkb1-/-; CD4Cre Rela fx/fx' vs 'wild type genotype' | genotype | RNA-seq of CD8 single positive thymocytes from WT and Rela fx/fx CD4Cre Nfkb1KO RelKO mice. |
-1.2 | | Oasl2 | 'heterozygous RYR1 mutant' vs 'RYR1 wild type' in 'embryonic day 14.5' | developmental stage, genotype | Microarrays of mouse embryonic limb skeletal muscle at days E14.5 and E18.5 lacking the RYR1 or Cav1.1 Ca2+ channels |
-1.2 | | Oasl2 | 'Porphyromonas gingivalis; hyperlipidemia' vs 'Porphyromonas gingivalis; normal' | infect, phenotype | hyperlipidemia impaired innate response |
-1.2 | | Oasl2 | 'B117H; cytosine arabinoside resistant' vs 'B117P; cytosine arabinosine sensitive' | cell line, phenotype | Gene expression profile of two Ara-C-resistant cell lines |
1.2 | | Oasl2 | 'Trichuris muris' vs 'control' in 'mesenteric lymph node' | environmental stress, infect, organism part | RNA-seq of mouse intestinal mucosa to investigate infection by the parasitic nematode Trichuris muris |
1.2 | | Oasl2 | 'transgenic' vs 'wild type' in '121 day; 129Sv' | age, genotype, strain | Whole genome transcriptome analysis identifies indices of fast and slow disease progression in two ALS mouse models |
-1.2 | | Oasl2 | 'Lmna G609G/G609G knock in' vs 'wild type' | genotype | Transcription profiling by array of mouse liver with Lmna Gly609Gly knock in |
1.2 | | Oasl2 | 'B4053; RML infected' at '7 week' vs 'B4053; uninfected' at '7 week' | strain, time, treatment | Transcription profiling of mouse brain infected with prions in eight mouse-prion strain combinations in a systems approach to the study of prion disease |
1.2 | | Oasl2 | 'NEMO knockout' vs 'wild type' | genotype | TNFR1 controls apoptosis and chronic liver disease in hepatocyte-specific IKKγ (Nemo) mice. |
1.2 | | Oasl2 | 'Notch 1 and 2 null' vs 'wild type' | genotype | Quantitative Analysis of Notch mutant (Notch1&2-null, Psen1&2-null, RBPjk-null) and wild-type hair follicle transcriptomes by NGS |
1.2 | | Oasl2 | 'NEMO-TNFR1 double knockout' vs 'wild type' | genotype | TNFR1 controls apoptosis and chronic liver disease in hepatocyte-specific IKKγ (Nemo) mice. |
1.2 | | Oasl2 | 'irf4-/-' vs 'wild type genotype' | genotype | Transcription profiling by array of mouse irf4 knockout mature splenic B cells against wild type controls from littermates |
1.2 | | Oasl2 | 'trehalose dimycolated (TDM)' at '24 hour' vs 'phosphatidylglycerol (PG) control' at '24 hour' | stimulus, time | Transcription profiling by array of mouse bone marrow-derived macrophages stimulated by trehalose dimycolated (TDM) or phosphatidylglycerol (PG) control to study how mycobacterial TDM reprograms macrophage global gene expression |
1.2 | | Oasl2 | 'CpG ODN' vs 'PBS' at '48 hour' | compound, time | Transcription profiling by array of mouse vaginal samples following adjuvant treatment |
-1.2 | | Oasl2 | 'brown adipose tissue' vs 'white adipose tissue' in 'chow; 23 degree celsius' | diet, organism part, temperature | RNA-seq of brown and white mouse adipose tissue at thermoneutrality and high-fat diet |
1.2 | | Oasl2 | 'cardiotoxin; 40 microliter' vs 'none' in 'wild type' at '12 day' | compound, genotype, time | Transcription profiling by array of mouse skeletal muscle expressing CnAa or CnAb1 under the control of the MLC promoter after treatment with cardiotoxin |
-1.2 | | Oasl2 | 'organoid culture without Noggin (ER medium)' vs 'organoid culture (ENR medium)' in 'none' | growth condition, stimulus | RNA-seq of small intestinal organoids treated with the control medium ENR (EGF, Noggin, R-spondin1) in the presence or absence of muscle supernatant |
1.2 | | Oasl2 | 'Dcrfx/fx;MisCre' vs 'wild type' in '5 day' | age, genotype | Transcription profiling of testis from wild type mice and mice with a Sertoli-specific ablation of Dicer |
1.2 | | Oasl2 | 'BL6; 301V infected' at '24 week' vs 'BL6; uninfected' at '24 week' | strain, time, treatment | Transcription profiling of mouse brain infected with prions in eight mouse-prion strain combinations in a systems approach to the study of prion disease |
1.2 | | Oasl2 | 'BL6; RML infected' at '14 week' vs 'BL6; uninfected' at '14 week' | strain, time, treatment | Transcription profiling of mouse brain infected with prions in eight mouse-prion strain combinations in a systems approach to the study of prion disease |
1.2 | | Oasl2 | 'stem cell of gastric corpus gland' vs 'epithelial cell of stomach' | cell type | Bulk RNA-seq of proliferating cells in the mouse stomach corpus epithelium from FUCCI mouse. |
1.2 | | Oasl2 | 'dox-induced over-expression of oncogenes for 5 days then off 7 days' vs 'untreated control' | phenotype | Temporal Transcriptional Profiling in response to cMYC and KrasG12D Expression and Inactivation in In Vitro Cultured Primary Mammary Epithelial Cells of Adult Virgin Mice |
1.2 | | Oasl2 | 'etoposide; 2.5 micromolar' vs 'none' in 'wild type genotype' | compound, genotype | RNA-seq of H2afj-ko and isogenic WT C57/Bl6-N mouse embryonic fibroblasts in proliferation and after etoposide-induced senescence. |
1.2 | | Oasl2 | '10 microgram; ovalbumin' vs 'none' in 'wild type' | compound, genotype | Transcription profiling by array of lungs from mice mutant for RAG after challenge with ovalbumin |
-1.2 | | Oasl2 | 'Macrophage of F4/80+, CD11b+, CD11c-; obese leptin-deficient' vs 'Macrophage of F4/80+, CD11b+, CD11c-; control' | cell type, genotype | Expression data from mouse adipose tissue macrophage |
1.2 | | Oasl2 | 'CKIαΔgut/p53R172H' vs 'CKIαΔgut/p53Δgut' in 'jejunum' | compound, genotype, organism part | RNAseq of enterocytes of the jejunum and Ileum from transgene C57BL/6 mice harboring a CKIαΔgut knock-out |
-1.2 | | Oasl2 | 'inducible deletion of Mll' vs 'control' | treatment | MLL regulated genes in LSK/CD48- hematopoietic stem cells |
-1.2 | | Oasl2 | 'FusΔNLS/+' vs 'wild type genotype' at '8 hour' | genotype, time | Mutant FUS triggers age-dependent synaptic impairment in presymptomatic ALS-FUS mice (RNA-seq part2) |
1.1 | | Oasl2 | 'CD4-positive T cell' vs 'CD8-positive T cell' in 'Egr2 and Egr3 knockout' | cell type, genotype, phenotype | RNAseq analysis of CD4 and CD8 T cells in response to vaccinia virus infection |
-1.1 | | Oasl2 | 'M-CSF and FSL-1' at '6 day' vs 'none' at '0 day' | compound, time | Microarray profiling of polyploid macrophage progeny |
-1.1 | | Oasl2 | 'M-CSF and FSL-1' at '3 day' vs 'none' at '0 day' | compound, time | Microarray profiling of polyploid macrophage progeny |
-1.1 | | Oasl2 | 'Abcc8-/-' vs 'wild type genotype' in 'high fat; female' | diet, genotype, sex | Effects of increased intracellular calcium and overnutrition on pancreatic beta cell transcriptome |
1.1 | | Oasl2 | 'R6/2' vs 'wild type genotype' | genotype | Gene expression data from cortex of 9 week old wild type, R6/2, HDAC4het and R6/2::HDAC4het mice |
1.1 | | Oasl2 | 'Miz1 siRNA' vs 'non-targeting siRNA' | RNA interference | RNA-SEQ analysis of KMC murine pancreatic ductal adenocarcinoma (PDAC) cell line upon siRNA depletion of MYC, KRas or Miz1 (aka Zbtb17) |
1.1 | | Oasl2 | 'ATF3 -/-' vs 'wild type' in '10 nanogram per milliliter; lipopolysaccharide' at '1 hour' | compound, genotype, time | Transcription profiling by array of mouse bone marrow macrophages mutant for ATF3 after treatment with lipopolysaccharide |
-1.1 | | Oasl2 | 'interleukin-4; 20 nanogram per milliliter' vs 'none; ' | compound | Genome-wide analysis of mouse macrophages stimulated with IL-4 (bone marrow macrophages) (Affymetrix) |
1.1 | | Oasl2 | 'postnatal day 12' vs 'postnatal day 1' in 'insulin-expressing immature beta cell' | cell type, developmental stage | Transcription profiling by high throughput sequencing of murine beta cells at key stages of maturation |
1.1 | | Oasl2 | '7 days P. chabaudi infected' vs 'uninfected' in 'gonadectomized female' | clinical information, disease, sex, time | Transcription profiling by array of mice infected with Plasmodium chabaudi after gonadectomization to investigate involvement of gonadal steroids |
1.1 | | Oasl2 | 'transgenic hepatic growth hormone' vs 'wild type genotype' in '12 week' | age, genotype | Hepatic Deletion of Janus Kinase 2 Counteracts Inflammation, Oxidative Stress and Liver Cancer Formation in Growth Hormone Transgenic Mice |
1.1 | | Oasl2 | 'intestinal smooth muscle culture supernatant' vs 'none' in 'organoid culture (ENR medium)' | growth condition, stimulus | RNA-seq of small intestinal organoids treated with the control medium ENR (EGF, Noggin, R-spondin1) in the presence or absence of muscle supernatant |
1.1 | | Oasl2 | 'calorie restricted diet' vs 'normal diet' at '15 month' | age, diet | Transcription profiling by array of cochleae from mice fed a calorie-restricted diet |
1.1 | | Oasl2 | 'Gucy2c S839I mutant' vs 'wild type genotype' | genotype | Transcriptomic analysis of the distal colon of wild type C57BL/6N mice and mice harboring a mutation (S839I) in Gucy2c |
1.1 | | Oasl2 | 'antibiotics, CCl4 and diethylnitrosamine' vs 'none' in 'wild type genotype' | genotype, treatment | Gene expression accompanying the promotion of hepatocellular carcinoma by intestinal microbiota and Tlr4 in mice. |
-1.1 | | Oasl2 | 'CD45.2+MHCII-/- bone marrow to CD45.1+ WT' vs 'wild type' in 'naive CD4+ T cell' | cell type, genotype | Generating mouse model with predominant naïve or innate memory phenotype CD4+ T cells |
1.1 | | Oasl2 | 'postnatal 2-3 month; hindlimb' vs 'embryonic day 17.5; whole forelimb and hindlimb' | age, organism part | Expression data from skeletal muscle satellite cells at different development stages |
-1.1 | | Oasl2 | 'beta(3)-adrenergic agonist Cl316,243' vs 'none' at '10 week' | age, stimulus | RNA-seq of age-associated transcriptome changes in brown adipose tissue |
1.1 | | Oasl2 | 'Pkhd1Cre; Pkd2 F/F' vs 'wild type' | genotype | Next Generation Sequencing of PKD2 mutant mice kidneys |
1.1 | | Oasl2 | 'chronic DSS-induced colitis; 2x DSS, additional recovery' vs 'none; none' | clinical treatment, disease | Transcription profiling by array of colon tissues isolated from mice with acute and chronic dextran sodium sulphate (DSS)-induced colitis |
-1.1 | | Oasl2 | 'tape stripping' vs 'control' | treatment | Transcription profiling by array of mouse dorsal skin after tape stripping and treatment with winged bean extract. |
1.1 | | Oasl2 | '14M1.4; Leishmania donovani infected' at '48 hour' vs '14M1.4; normal' at '48 hour' | cell line, infect, time | Transcription profiling of 3 mouse cell lines infected with Leishmania |
1.1 | | Oasl2 | 'Lsd1fl/fl Mx1Cre' vs 'Lsd1fl/fl' | genotype | Gene expression data of Lsd1fl/fl and Lsd1fl/fl Mx1Cre Gr1dim Mac1 granulocytic progenitor cells. |
-1.1 | | Oasl2 | 'conditional UPF2 knockout; before partial hepatechtomy' vs 'control; before partial hepatechtomy' | genotype, sampling time | Transcription profiling of livers of adult UPF2 null mice in response to partial hepatechtomy |
1.1 | | Oasl2 | '14 days P. chabaudi infected' vs 'uninfected' in 'intact male' | clinical information, disease, sex, time | Transcription profiling by array of mice infected with Plasmodium chabaudi after gonadectomization to investigate involvement of gonadal steroids |
1.1 | | Oasl2 | 'K14-Cre-ERT2 / CK1α fl/fl; 4-hydroxytamoxifen; none; 14 day' vs 'K14-Cre-ERT2; none; none' | genotype, irradiate, time | Ablation of casein kinase 1 in keratinocytes induces p53-dependent hyperpigmentation of the skin |
-1.1 | | Oasl2 | 'E-FABP knockout' vs 'wild type' | genotype | Gene expression microarray data of bone marrow derived macrophages using GM-CSF(GM-BMMs) co-cultured with E0771 breast tumor cells |
-1.1 | | Oasl2 | 'IFNAR1 -/-' vs 'wild type genotype' in 'SARS coronavirus MA15' at '5 day' | genotype, infect, time | Transcriptomic analysis of host response to mouse-adapted SARS virus in wild type, STAT1 -/-, and IFNAR1 -/- mouse genetic backgrounds |
1.1 | | Oasl2 | 'Alb-Cre;VHLf/f' vs 'Alb-Cre' | genotype | Transcription profiling by array of mice with liver-specific expression of hypoxia inducible factor, or inactivated von Hippel-Lindau tumor suppressor |
1.1 | | Oasl2 | 'old neuronal stem cells' vs 'young neuronal stem cells' | age | A mechanism for the segregation of age in mammalian neural stem cells |
-1.1 | | Oasl2 | 'Kaiso knockout' vs 'wild type phenotype' | phenotype | Gene expression microarray analysis of whole intestine from Kaiso-/- mice |
1.1 | | Oasl2 | 'wormy, worm left; Trichuris muris' vs 'control; non wormy' in 'caecum' | environmental stress, infect, organism part | RNA-seq of mouse intestinal mucosa to investigate infection by the parasitic nematode Trichuris muris |
-1.1 | | Oasl2 | 'normal skin; PKC alpha-/-' vs 'normal skin; wild type genotype' | clinical history, genotype | Altered dermal architecture in PKCα-/- skin |
1.1 | | Oasl2 | 'fl-p300/Foxp3cre' vs 'wild type' | genotype | Two Histone/Protein Acetyltransferases, CBP and p300, Are Indispensable for Foxp3+ T-regulatory Cell Development and Function |
1.1 | | Oasl2 | 'R6/2 transgenic' vs 'wild type' in '8 week; brain cortex' | age, genotype, organism part | Transcription profiling by high throughput sequencing in wild type and R6/2 mutant mouse cortex and striatum at 8 and 12 weeks. |
1 | | Oasl2 | 'AZD8835; 50 milligram per kilogram' vs 'none' at '14 day' | compound, time | RNAseq of tumor samples from CT26 syngeneic mouse treated with a PI3Ka/d inhibitor (AZD8835) |
1 | | Oasl2 | 'α-GalCer; 2 microgram' vs 'none' in 'Cd1d homozyous knockout' | compound, genotype | CD1d-dependent immune suppression mediated by regulatory B cells through modulations of iNKT cells |
1 | | Oasl2 | '336 hour' vs '0 hour' on 'Affymetrix Mouse430A_2 Array' | time | Transcription profiling of murine V6.5 embryonic stem cells differentiating into embryoid bodies over a time-course to study changes in transcription during stem cell differentiation |
-1 | | Oasl2 | 'Abcc8 knockout' vs 'wild type' | genotype | Transcription profiling by high throughput sequencing of pancreatic beta cells from wild type and Abcc8 knockout mice |
1 | | Oasl2 | 'R6/2' vs 'wild type genotype' | genotype | Gene expression data from cortex of 15 week old wild type, R6/2, HDAC4het and R6/2::HDAC4het mice |
-1 | | Oasl2 | '500 micromolar palmitate' vs '1 volume percent bovine serum albumin' | compound | Transcription profiling of mouse C2C12 myotubes treated overnight with 500 uM palmitate or 1% bovine serum albumin control to identify mediators of obesity-linked reductions in PGC-1 |
1 | | Oasl2 | '3110043O21Rik knockout; spleen' vs 'wild type genotype; spleen' | genotype, organism part, sampling site | RNAseq of coding RNA in the liver, spleen, kidney, abdominal muscle and gonadal adipose tissue of knock out mice and wild type controls. |
1 | | Oasl2 | 'Metarhizium anisopliae crude antigen' vs 'vehicle' at '12 hour' | compound, time | Transcription profiling of mouse lungs following exposure to agents of high or low allergenicity |
1 | | Oasl2 | 'Western diet' vs 'control diet' | diet | transcription profiling by array of C57BL/6J mice fed a Western-style diet with or without 0.05% quercetin against mice on a control diet to study the effect of quercetin on obesity and hepatic gene expression |
1 | | Oasl2 | 'Roquinsan/san(sanroque)' vs 'wild type' | genotype | Expression data from CD44loCD8+ T cells of sanroque versus wild-type mice |
1 | | Oasl2 | 'Ercc1 knock out' vs 'wild type' | genotype | Transcription profiling by array of liver from mice mutant for Ercc1 |
1 | | Oasl2 | 'MFP2 knockout' vs 'wild type' | genotype | Defining the microglia transcriptome in multifunctional protein-2 deficient mice |
1 | | Oasl2 | '18 week; R6/1 transgenic' vs '18 week; wild_type' | age, genotype | Transcription profiling of HD R6/1 transgenic mouse line brain hemispheres, time series |
1 | | Oasl2 | 'AUY922; 100 nanomolar' vs 'DMSO; 0.1 percent' in 'Mll1 knockout' | compound, genotype | Identification of targets regulated by MLL1 in response to HSP90 inhibitors |
1 | | Oasl2 | 'heart-specific p53 and Mdm2 knockout; 7 day' vs 'heart-specific p53 and Mdm2 knockout; 1 day' | phenotype, time | Transcription profiling of heart tissue from mice with heart-specific knockout of p53 and Mdm2 |
-1 | | Oasl2 | 'Ngn3-expressing cell' vs 'Ngn3-null cell' | cell type | Transcriptional profiling of Ngn3-dependent pancreatic endocrine differentiation at E15.5 |
1 | | Oasl2 | 'Staphylococcus aureus Sanger476; 2 hour' vs 'none; 0 hour' in 'A/J' | infect, strain, time | Gene Expression-Based Classifiers Identify Staphylococcus aureus Infection in Mice and Humans |
1 | | Oasl2 | '24 hour' vs '0 hour' in 'WT1+KTS' | genotype, time | EWS-WT1 Oncogene Activates a Neuronal Reprogramming Factor ASCL1 and Mediates Partial Neural Differentiation |
-1 | | Oasl2 | 'ABIN1[D485N] knock-in' vs 'wild type genotype' in 'non-classical monocyte' | cell type, genotype | RNA-seq of inflammatory monocytes, patrolling monocytes and neutrophils in wild type and ABIN1[D485N] mice |
1 | | Oasl2 | 'Trem2 knockout, 5XFAD transgenic' vs 'wild type' | genotype | Transcription profiling by array of microglia purified from wild type and TREM2 deficient microglia in a mouse model of Alzheimer's disease |
-1 | | Oasl2 | 'caloric restriction' vs 'ad libitum' in 'PPARg flox/flox; Villin-Cre' | diet, genotype | Microarray for duodenum epithelium of C57Bl6 PPARgVillinCRE and wild type mice submitted to 2 weeks 75% caloric restriction compared to ad libitum fed controls |
1 | | Oasl2 | 'Sall4 homozygous knockout' vs 'wild type genotype' | genotype | RNA-Seq of Sall4 mutants in mouse embryonic stem cells |
1 | | Oasl2 | 'ribonucleic acid expressing respriatory syncytial virus F protein' vs 'phosphate buffered saline' | stimulus | Microarray analysis of mouse whole genome using self-amplifying messenger (SAM) RNA delivered with different formulations compared to controls |
1 | | Oasl2 | 'Escherichia coli O18:K1:H7; 2 hour' vs 'none; 0 hour' in 'A/J' | infect, strain, time | Gene Expression-Based Classifiers Identify Staphylococcus aureus Infection in Mice and Humans |
-1 | | Oasl2 | 'HoxA11 HoxD11 null' vs 'wild type' in 'metanephric mesenchyme' | genotype, organism part | Transcription profiling by array of wild type and HoxA11 metenephric mesenchyme and ureteric bud from embryonic day 11.5 mice |
-1 | | Oasl2 | 'SARS coronavirus MA15 dORF6' vs 'SARS coronavirus MA15' at '1 day' | infect, time | SM012 - SARS MA15 wild type, and SARS deltaORF6 mutant virus infections of C57BL6 mice - A time course |
1 | | Oasl2 | 'Myd88 -/-' vs 'wild type genotype' in 'raised in conventional environment; proximal colon' | environmental history, genotype, organism part | Transcriptional profiling of intestinal tissue samples from germ-free and conventionally raised mice which are either wild-type or Myd88-/- |
1 | | Oasl2 | 'smoke; 2250 microgram' vs 'control; 0 microgram' in 'Nrf2 knockout' at 'after 5 month exposure and 1 day post-exposure' | compound, genotype, sampling time point | Transcription profiling by array of Nrf2 knockout mice exposed to cigarette smoke |
1 | | Oasl2 | 'Crx knockout' vs 'control' at '6 zeitgeber' | genotype, time | Transcriptome in 129sv and Crx-/- pineal gland at ZT (Zeitgeber time) 6 and ZT20 |
1 | | Oasl2 | 'Apc and Msx1 knockout in Villin1 positive cells' vs 'wild type' | phenotype | Transcription profiling by array of Apc-deficient proximal colonic epithelium upon Msx1 transcription factor depletion |
1 | | Oasl2 | 'alphaGalCer' vs 'PBS/Tween 0.5%' at '48 hour' | compound, time | Transcription profiling by array of mouse vaginal samples following adjuvant treatment |
-1 | | Oasl2 | 'RA-treated' vs 'control' in 'Hepatic RXR_alpha-Knockout' | genotype, treatment | Gene expression data of untreated and RA-treated wild type and RXRα-deficient mice liver |
1 | | Oasl2 | 'carcinoma' vs 'normal' | disease | Gene expression profile between normal mouse skin and carcinomas arising in the skin of RbF/F;K14creERTM;p107-/- mouse |
1 | | Oasl2 | 'Apc knockout in Villin1 positive cells' vs 'wild type' | phenotype | Transcription profiling by array of Apc-deficient proximal colonic epithelium upon Msx1 transcription factor depletion |
1 | | Oasl2 | 'overexpression of SRC-2' vs 'control' | phenotype | A pivotal role of SRC-2 in Metastatic and Castration Resistant Prostate Cancer |
1 | | Oasl2 | 'tumor' vs 'normal' in 'kidney' | clinical information, organism part | Premature termination of in vivo reprogramming leads to cancer development through altered epigenetic regulation [array] |
1 | | Oasl2 | 'wormy, worm separated; Trichuris muris' vs 'control; non wormy' in 'caecum' | environmental stress, infect, organism part | RNA-seq of mouse intestinal mucosa to investigate infection by the parasitic nematode Trichuris muris |